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ABSTRACT 
 
Composite scaffolds of polycaprolactone (PCL) and bovine derived hydroxyapatite 
(HA) were produced by blending HA into PCL solution followed by electrospinning. 
This study mainly focused on studying the materials morphology, characteristics and 
interactions between the materials and cells. Six groups of scaffolds based on the weight 
ratio of HA in proportion to PCL were prepared (0%, 10%, 20%, 30%, 40% and 50%). 
The scaffolds were studied by infra-red spectroscopy (FTIR), 3D confocal laser 
microscopy and field emission scanning electron microscopy (FESEM) in order to 
determine the chemical and thermal properties as well as imaging the scaffold to cell 
interactions. Bone Marrow Stem Cell (BMSC) proliferation assays were carried out on 
Days 1, 7 and 14 using Resazurin, Deoxyribonucleic Acid (DNA) and Alkaline 
Phosphatase (ALP) measurements. DNA levels were used to identify cell presence and 
possible proliferation. ALP levels were used to indicate possible stem cell 
differentiation to osteoblasts. It was observed that with increasing amounts of HA in the 
PCL scaffold, the quantity and quality of cell attachment increased. Our study shows 
that the electrospun nanofibres of PCL incorporated with micro particles of HA could 
provide a scaffold that could be applied successfully in bone tissue engineering. 
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ABSTRAK 	  Perencah	  komposit	  polycaprolactone	  (PCL)	  dan	  bovine	  hydroxyapatite	  (HA)	  telah	  dihasilkan	   dengan	   menggabungkan	   HA	   ke	   dalam	   larutan	   PCL	   diikuti	   dengan	  elektroputaran.	   Enam	   kumpulan	   perencah	   berdasarkan	   nisbah	   berat	   HA	  berkadaran	   dengan	   PCL	   telah	   disediakan	   (0%,	   10%,	   20%,	   30%,	   40%	  dan	   50%).	  Perencah	  telah	  dikaji	  dengan	  spektroskopi	  inframerah	  (FTIR)	  ,	  mikroskopi	  sefokus	  laser	   3D	   dan	   pelepasan	   bidang	   elektron	   imbasan	   mikroskopi	   (FESEM)	   untuk	  menentukan	   sifat	   kimia,	   sifat	   haba	   dan	   juga	   pengimejan	   perencah	   interaksi	   sel.	  Ujian	   percambahan	   sel-­‐sel	   stem	   sum-­‐sum	   tulang	   (BMSC)	   telah	   dijalankan	   pada	  Hari	  1,	  7	  dan	  14	  menggunakan	  Resazurin,	  Asid	  Deoksiribonuklik	  (DNA)	  dan	  Alkali	  Phosphatase	   (ALP)	   sebagai	   ukuran.	   Kehadiran	   DNA	   telah	   digunakan	   untuk	  mengenal	   pasti	   adanya	   sel	   dan	   perkembangannya.	   Tahap	   ALP	   telah	   digunakan	  untuk	   menunjukkan	   kemungkinan	   pembezaan	   sel-­‐sel	   stem	   kepada	   osteoblas.	  Diperhatikan	   bahawa	   dengan	   peningkatan	   jumlah	   HA	   dalam	   perencah	   PCL,	  kuantiti	   dan	   kualiti	   lampiran	   sel	   meningkat.	   Kajian	   kami	   menunjukkan	   bahawa	  nanofiber	   PCL	   elektroputar	   digabungkan	   dengan	   partikel	   mikro	   HA,	   boleh	  menyediakan	   satu	   perencah	   yang	   boleh	   digunakan	   dengan	   jayanya	   dalam	  kejuruteraan	  tisu	  tulang.	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CHAPTER 1:   INTRODUCTION 	  
1.1 A Brief Overview of Tissue Engineering: History and Definition  
 
Tissue engineering is a relatively new field, first comprehensively defined by Robert Langer 
from the Massachusetts Institute of Technology in 1988. The most cited publication in the 
history of tissue engineering regards the birth of this field, and was published by Langer and 
Vancini (1993) in Science. In it they described their definition of tissue engineering, which 
has come to be regarded as a more-or-less universal definition. They define tissue 
engineering as “an interdisciplinary field that applies the principles of engineering and life 
sciences toward the development of biological substitutes that restore, maintain, or improve 
tissue function or a whole organ”. It’s definition continues to morph from the original form, 
and the most current definition is the use of a combination of cells, engineering and 
materials, methods, and suitable biochemical and physio-chemical factors to improve or 
replace biological functions (Barnes and Harris, 2008). The terms “regenerative medicine” 
and “tissue engineering” are very closely linked, however they differ in that regenerative 
medicine generally involves the use of stem cells and tissue engineering may or may not 
involve the use of cells (Riazi et al., 2009). 
 
Tissue engineering mostly deals with resolving health-related issues that affect organs and 
their tissues. These include, but are not limited to, diseases of the bone, cartilage, blood 
vessels, bladder, skin and muscles. The use of biomaterials in trying to solve tissue 
engineering related issues are growing and has been well documented in many journals, with 
one journal (Biomaterials) being exclusively dedicated to advances and innovation in the use 
of biomaterials. 
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A lot of hope rests on tissue engineering, particularly for its potential in combating problems 
related to organ damage, replacement, and return of functionality. Chaignaud et al. (1997), 
defined tissue-engineering technology as that which combines the study of engineering, cell 
and molecular biology, materials science, and surgery, toward the development of biological 
substitutes that restore, maintain, and improve the function of damaged tissues and organs. 
 
According to a definition provided by the National Institute of Health (USA), the pillars of 
tissue engineering are found in its therapeutic and diagnostic applications. These 
applications try to maximize the use of both cells and materials. In diagnostic applications of 
tissue engineering, in-vitro cultured tissues, cells or both are used for assessing drug toxicity, 
pathogenicity and effectiveness. As far as therapeutic applications are concerned, tissue 
engineering deals with the use of:  
1) Biomaterials: including novel biomaterials that are designed to direct the organization, 
growth, and differentiation of cells in the process of forming functional tissues by providing 
both physical and chemical cues.  
2) Cells: including enabling methodologies for the proliferation and differentiation of cells, 
acquiring the appropriate source of cells such as autologous cells, allogeneic cells, 
xenogeneic cells, stem cells, or genetically engineered cells, and the use of immunological-
manipulation.  
3) Biomolecules: including angiogenic factors, growth factors, differentiation factors and 
bone morphogenic proteins. 
4) Engineering Design Aspects: including 2-d cell expansion, 3-d tissue growth, 
bioreactors, vascularization, cell and tissue storage, and shipping (biological packaging).  
5) Biomechanical Aspects of Design: including properties of native tissues, identification 
of minimum properties required of engineered tissues, mechanical signals regulating 
engineered tissues, and the efficacy and safety of engineered tissues. 
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6) Informatics to support tissue engineering: gene and protein sequencing, gene expression 
analysis, protein expression and interaction analysis, quantitative cellular image analysis, 
quantitative tissue analysis, in silico tissue and cell modelling, digital tissue manufacturing, 
automated quality assurance systems, data mining tools, and clinical informatics interfaces. 
Figure 1.1 explains the process of tissue engineering. 
 
 
Figure 1.1: Principles of tissue engineering (redrawn based on A.K. Saxena, 2010) 
 
 1.1.1   Bone tissue engineering 
  1.1.1.1 Anatomy and physiology of bone 
	  
Bones form an integral part of the body and have an anatomic structure that consists of very 
dense connective tissue. Forming the skeleton of the human body, they are found in various 
sizes and shapes. Mineralized bone tissue, also known as osseous tissue, forms a rigid 3-
dimensional structure that helps maintain the structure of the bone. Bone tissue has two 
SCAFFOLD	  
(one	  can	  opt	  for	  
either	  2D	  or	  3D	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on	  <inal	  
transplantation/
implantation	  site	  
CONSTRUCT-­‐involves	  
seeding	  in	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  and	  
culturing	  
TISSUE	  GENERATION	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  involves	  
the	  use	  of	  a	  
Bioreactor)	  
TRANSPLANTATION	  
(depends	  on	  site	  	  in	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  the	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CELL	  ISOLATION,	  
SEEDING	  AND	  
PROLIFERATION	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main classifications; it is either compact or spongy. The dense layer that forms the exterior 
of the bone is the compact layer and the spongy layer is the layer that has a lot of pores in 
between, the bone trebeculae forms a network inside the bone (Figure 1.2). The 
classification of bone itself is performed based on the shape and size of the bone; e.g. long 
bones (e.g. tibia, femur), short bones (e.g. carpals), flat bones (e.g. skull), and irregular 
bones (e.g. vertebra). A long bone has a shaft called diaphysis, with two enlarged ends 
called epiphysis. The flared portion between the diaphysis and epiphysis is called 
metaphysis. The inner portion of the bone is a large cavity that is filled with bone marrow, 
called marrow or medullary cavity. 
 
Figure 1.2: Compact and Spongy Bone (picture obtained from National Cancer                    
Institute, United States). 
 
The surface of the bone is enveloped by periosteum. The periosteum consists of an outer 
fibrous layer that resembles other dense connective tissue, and an inner cellular layer 
containing osteoprogenitor cells or periosteal cells. The periosteal cells are capable of 
differentiating into osteoblasts under appropriate stimulus. The endosteum is the lining 
tissue of both the compact bone facing the marrow cavity and the trabeculae of spongy bone 
within the cavity. This endosteum consists of fibroblastic flattened cells or called endosteal 
cells, cells capable of differentiating into osteoblasts under appropriate stimulus (Ross et al., 
1995). 
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  1.1.1.2   Bone fracture and repair 	  
When bone fractures, an initial response, which is similar to any injury, occurs - tissue 
destruction and haemorrhage. This is followed by a neutrophil invasion (which results in 
acute inflammation) macrophage debridement, fibroblast and capillary proliferation and 
growth, tissue granulation and finally cartilage or callus formation at the site of the injury. 
Meanwhile, osteoprogenitor cells of the periosteum proliferate and differentiate into 
osteoblasts and begin to deposit new bone matrix on the outer surface of the bone some 
distance from the fracture. These cells progress toward the fracture site until new bone 
forms as a bony sheath over the fibrocartiliginous callus (Figure 1.3).  
 
This newly formed bone will then invade the callus and lay down new bone matrix within 
the callus, gradually replacing the callus, described as endochondral ossification. Similarly, 
in the marrow cavity, endosteal proliferation and differentiation give rise to medullary bone 
growth from the both ends of the fracture toward the centrecentre, where unite and spongy 
bone is then formed. This spongy bone is gradually replaced by compact bone, and the bony 
callus is removed and remodelled by the action of osteoclasts. In healthy individuals, this 
process usually takes from six to twelve weeks, depending on the severity of the break and 
the particular bone that is broken (Ross et al., 1995; Chin, 2006). 
	   
 
Figure 1.3: Repair of bone (reproduced from Essentials of Human anatomy and 
Physiology, edited by Elaine N. Marieb, 2008) 
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1.2 Electrospinning 
 
The earliest record of electrospinning was in the 16th century when William Gilbert 
described the behaviour of magnetic and electrostatic phenomena. It basically involves 
creating electrospun fibres on a nano scale that can be spun into sheets and used for a variety 
of purposes. The properties of electrospinning contain the features of electrospraying and 
conventional solution dry spinning of fibres. The process does not require the use of 
coagulation chemistry or high temperatures to produce solid threads from the solution. This 
makes the process particularly suited to the production of fibres using large and complex 
molecules (Ziabicki, 1976).  
 
Figure 1.4: An electrospinning experimental layout (reproduced from Sun et al., 2012) 
 
One attractive feature of electrospinning is the relative simplicity and cost effective nature 
of the setup; the typical electrospinning setup consists of a syringe pump, a high voltage 
source, and a collector (Figure 1.4). In the process of fabricating an electrospun polymer, the 
polymer solution is held at a needle tip by surface tension. The application of an electric 
field using the high-voltage source causes charge to be induced within the polymer, resulting 
in charge repulsion within the solution. This electrostatic force opposes the surface tension; 
ultimately, the charge repulsion overcomes the surface tension, causing the initiation of a jet 
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As this jet travels, the solvent evaporates and an appropriate collector (often an aluminium 
sheet) can be used to capture the polymer fibre (Pham et al., 2006) and by sequential 
layering, a sheet is formed.  
 
Parameters that control the process of electrospinning are solution properties, controlled 
variables, and ambient parameters. The solution properties include the viscosity, 
conductivity, surface tension, polymer molecular weight, dipole moment, and dielectric 
constant. The effects of the solution properties can be difficult to isolate since varying one 
parameter can generally affect the other solution properties (e.g. changing the conductivity 
can also change the viscosity). Controlled variables include the flow rate, electric field 
strength, distance between tip and collector, needle tip design, and collector composition 
and geometry. Ambient parameters include temperature, humidity, and air velocity (Doshi 
and Reneker, 1995). All these parameters have to be looked at carefully prior to 
electrospinning a solution blend. 
 
1.3 Bone Marrow Stem Cells 
 
There are two kinds of stem cells found in bone marrow, namely the Hematopoietic Stem 
Cells (HSCs) and the Mesenchymal Stem Cells (MSCs). HSCs are capable of differentiating 
into several lineages of hematopoietic cells, such as neutrophils, eosinophils, monocytes, T-
lymphocytes, B-lymphocytes, erythrocytes and platelets. MSCs found in bone marrow are 
cells that are capable of differentiating into several types of connective tissues. Mesencymal 
Stem Cells (MSCs), also known as Marrow Stromal Cells (Adel and Mao, 2004), are 
defined as self-renewable, multipotent progenitor cells with the ability to differentiate into 
several distinct mesenchymal lineages, such as bone, cartilage, muscle, tendon, ligament and 
fat tissue (Caplan, 1991; Pittenger et al., 1999). In addition to differentiation into their 
	   	  9 
natural derivatives, MSCs have the potential to differentiate into other types of tissue-
forming cells. These include hepatic (Petersen et al., 1999; Shu et al., 2004), renal (Poulsom 
et al., 2003), pancreatic (Chen et al., 2004), pulmonary (Wu Min and Yu-Quan, 2004), 
cardiac (Orlic et al., 2001), and neural cells (Croft and Przyborski, 2004; Suon et al., 2004). 
 
Bone marrow-derived fibroblastic colonies were first successfully isolated from guinea pigs 
as described by Friedenstein et al. (1970), based on the adherence of marrow-derived 
fibroblastic cells to the plastic substrate of the cell culture plate and a concomitant lack of 
adherence of marrow-derived hematopoietic cells. These fibroblastic cells were found to be 
able to become osteocytes when implanted into recipient animals (Friedenstein et al., 1966). 
 
Bone marrow consists of 0.001% to 0.01% mesenchymal stem cells, but the high 
proliferation rate of these isolated mesenchymal stem cells enables them to be expanded 
over one billion-fold in culture (Haynesworth et al., 1992). However, the marrow-derived 
MSCs obtained by this technique are heterogeneous, which likely contain a variety of cells 
including fibroblasts, osteoblasts or osteoprogenitor cells, adipose cells, reticular cells, 
macrophages, endothelial and a fraction of hematopoietic stem cells (Seshi et al., 2000). 
Consequently, this has led to the investigation of the use of primary cultures of bone 
marrow-derived MSCs which enables one to culture more homogenous cell populations. 	  
1.4 Cell Studies and Existing Electrospun Scaffolds 	  
There is a constant innovation and research in the field of tissue engineering with regards to 
the production of scaffolds that are biocompatible, biodegradable and encourage the growth, 
proliferation and in some cases the differentiation of cells. Electrospun scaffolds are taking 
centre stage as more and more compounds are being mixed and their effects are being 
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studied. Polycaprolactone (PCL), a common polymer, is being used as a base solvent to 
which other materials, both organic and inorganic are being added to. PCL/gelatin 
nanofibrous scaffolds were seeded with fibroblasts and were tested for dermal reconstitution 
and wound healing (Chong et al., 2007). This combination was found to be highly effective 
in encouraging cell growth, adhesion and proliferation. Electrospun PCL/gelatin constructs 
were also used in nerve tissue engineering and were found to enhance the nerve 
differentiation potential and proliferation when compared to pure electrospun PCL 
constructs (Ghasemi-Mobarakeh et al., 2008). PCL has also been used with synthetic 
hydroxyapatite (HA) in an electrospun form with osteoblasts, however, in a 1:1 ratio of HA 
and PCL (Venugopal et al., 2008). The study compared mixtures of HA, Gelatin and 
Polycaprolactone. Venugopal et al. (2008), observed that the addition of HA to a PCL 
scaffold resulted in an increase in osteoblast proliferation over 6 days, and an increase in the 
amount of alkaline phosphatase produced over 10 days.  
 
The gap that has been identified in existing research is that whilst many studies have been 
performed using electrospun PCL and hydroxyapatite, there are not any studies performed 
on optimizing the concentration or ratio of Polycaprolactone to hydroxyapatite, or further 
observations identifying the optimal concentration of hydroxyapatite in terms of causing cell 
differentiation, in particular, differentiation from mesenchymal stem cells to osteoblasts. 
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1.5 Objectives 	  
1) To study the synthesis and characterize characterization of a biomaterial produced from 
bovine hydroxyapatite (BHA) and Polycaprolactone (PCL). 
2) Studying the effect of increasing BHA concentration in an electrospun PCL scaffold with 
regards to material morphology, characterisation, and cellular growth and interactions with 
the biomaterial produced. 
3) Studying the effect of increasing BHA concentration in an electrospun PCL scaffold on 
mesenchymal cell differentiation. 
4) Identifying the optimal BHA concentration in an electrospun PCL scaffold with regards 
to mesenchymal cellular differentiation to osteoblasts. 
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CHAPTER 2:   LITERATURE REVIEW 	  
2.1 Introduction 
 
This chapter will thoroughly discuss the existing sources of previously carried out similar 
experiments and will analyze the different segments involved in this research as well as 
discuss the reason for the successes and failures of the previous experimental setup. Looking 
at the overall picture, this thesis shall delve into research dealing with hydroxyapatite, 
polymer electrospinning, the effects of materials on the cell culture and the reasons for the 
different assays chosen. Additionally, there will be a discussion on the different biochemical 
assays present and the reasons behind their choice coupled with previous experimental work 
on those tests. 
 
2.2. Hydroxyapatite (HA)  
         2.2.1   Hydroxyapatite preparation  
 
Hydroxyapatite has many uses and has been well documented on its exceptional 
osteoconductive and bioactive properties. These attractive properties are present because of 
the similarity of hydroxyapatite with regards to its chemical and biological composition as 
well as its crystallographic composition to the mineral portions of hard tissue, e.g. bones and 
related tissues (Herliansyah, 2009 and Suchanek, 1998).  
 
There are many ways to produce hydroxyapatite and these include, but are not limited to, 
production of hydroxyapatite from inorganic synthesis, which would use the wet chemical 
method in aqueous solutions (Pramanik, 2005 and Kivrak, 1998). This method would 
involve making hydroxyapatite by using the inorganic oxides of calcium and phosphorus 
with additional additives and mixed in a ball mill for 16 hours followed by drying and then 
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shaping the dried hydroxyapatite into pellets and sintering them at 1250 °C. This was done 
until the stoichiometric ration of Ca/P of 1.6 was obtained, so as to confirm that the material 
formed was hydroxyapatite. Another method of producing hydroxyapatite from inorganic 
synthesis is the sol-gel method. This method has been used by Balamurugan (2002) and 
Layrolle (1998), and is used to make hydroxyapatite by mixing calcium acetate dissolved in 
ethandiol and a phosphorus precursor solution (which contains refluxed phosphorus 
pentoxide). These solutions were mixed with specific molar ratios which according to the 
authors (Balamurugan, 2002) ensured that the stoichiometric ratio of hydroxyapatite (Ca/P: 
1.67) was adhered to.  
 
Another method employed to produce hydroxyapatite is the hydrothermal method. This 
method (Majubala et al., 2000) involved the use of corals which were washed, dried and 
heated until 900 °C for 2 hours. The resultant powder was then mixed with diammonium 
hydrogen orthophosphate and water, with the solution under hydrothermal conditions for 
some hours to form hydroxyapatite.  
 
Another method to produce hydroxyapatite is the thermal deposition method. This was 
employed by Gross and Berndt (1997) to produce hydroxyapatite. Briefly what they did was, 
since they were creating hydroxyapatite coating, they sprayed spherical hydroxyapatite 
powder using a spray torch and then heat the powder up to 1400 °C and then run 
characterisation tests on the powder. Additionally as Tadic and Epple (2003) have shown, 
one can also produce hydroxyapatite by using the continuous precipitation method. The 
above mentioned are the more common chemical synthesis methods of hydroxyapatite. 
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 2.2.2   Hydroxyapatite sources 
 
Hydroxyapatite can be synthesized by extracting it from different sources. These sources 
include, but are not limited to, hydroxyapatite extracted from corals (Murugan and Rao, 
2002), egg shells (Sasikumar and Vijayaraghavan, 2006), cuttlefish shells (Rocha et al., 
2005 and Rocha et al., 2005), natural gypsum (Herliansyah et al, 2006), natural calcite 
(Herliansyah et al, 2007) and bovine bone (Ooi et al., 2007; Herliansyah et al., 2006 and 
Ruksudjarit et al., 2007). 
 
In particular, the focus will be on the extraction of hydroxyapatite from bovine bones, as this 
has been identified in previous studies (Ooi et al., 2007; Herliansyah et al, 2007) as being an 
easily available and pure source of hydroxyapatite. From Ooi et al. (2007), the means of 
extracting bovine hydroxyapatite was by using bovine bones, which was cut into various 
rectangular samples, defatted and annealed in an electric furnace under nine different 
temperatures which ranged from 400 °C to 1200 °C and they used a heating rate of 5 °C per 
minute with a 2 hour holding time. They then tested produced powder by X-ray Diffaction 
(XRD) and Fourier Transform Infrared (FTIR) spectroscopy and found that the best 
temperature for sintering bone powder to obtain bovine hydroxyapatite was above 700 °C as 
there were no secondary phases present in the bone matrix. Although they recommended the 
hydroxyapatite produced for clinical application, but they did not carry out any cellular 
studies on the produced scaffold. 
 
Herliansyah et al. (2006), defatted the bones by ensuring that the impurities were shaved and 
removed from the bones and then sun dried them for 3 days. The dried bone pieces were 
then cut into cubic pieces using a hacksaw and calcined at 5 temperatures ranging from 
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700 °C to 1100 °C, by increasing the temperature at a rate of 5 °C per minute and holding it 
for 2 hours to remove all organic matters.  
 
 2.2.3   Hydroxyapatite in Tissue Engineering 
 
Hydroxyapatite has been featured in tissue engineering as a pure scaffold itself and also as 
an additive to various polymers and other compounds and has then been tested on different 
types of cells (Kirkpatrick et al., 1998). 
 
A porous scaffold of HA was made and seeded with mesenchymal stem cells and observed 
that the cells proliferate within the scaffolds interconnected pores which aided bone tissue 
engineering by allowing the introduction and proliferation of bone cells and osteotropic 
agents into the scaffold. Their scaffold, which they named the IP-CHA (interconnected 
porous hydroxyapatite), when used in animal experiments showed superior osteoconduction, 
with a large portion of the pores being filled with newly formed bone (Yoshikawa and 
Myoui, 2005).  
 
Marra et al. (1999) made a hydroxyapatite scaffold composite using a polymer blend of PCL 
and HA as well as poly(lactic-co-glycolic) acid (PLGA) and HA. The method that they used 
for preparing the scaffolds was the particulate leaching technique which involved dissolving 
the polymers in chloroform which was used as a solvent and then suspending both sodium 
chloride (NaCL) and different concentrations of HA in the solution and then mixing the 
solution with distilled water.  
 
By performing biodegradability, histological, Scanning Electron Microscopy (SEM) and 
Transmission Electron Spectroscopy (TEM) analyses, they discovered that there was no 
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significant difference in terms of biodegradability between the different concentrations of 
HA. The SEM results showed cell growth on the surface of the seeded scaffolds at 2 and 4 
weeks. TEM displayed thick and confluent layers of cells on the surface of the scaffold. 
Histologically, what was observed was that the there was a positive stain for collagen and 
this was found more on the surface of the scaffold. It can be inferred from the experiment by 
Marra et al. (1999), that the vast majority of stem cells seeded on a scaffold containing HA 
and PCL generally tend to stay on the surface, so a thick 3-D scaffold should not be used, 
otherwise, it may hamper the migration and proliferation of cells. 
 
2.3 Polycaprolactone (PCL)  
 2.3.1   Properties and characteristics of Polycaprolactone 
 
Poly(ε-caprolactone) is normally made from ε-caprolactone via ring opening polymerization. 
Poly(ε-caprolactone) is generally semi-crystalline, with a melting point of 59 – 64 0C, glass-
transition temperature of -60 0C (Middleton and Tipton, 2000). Various copolymers based 
on ε-caprolactone have been synthesized, such as ε-caprolactone with DL-lactide (Kohn and 
Langer, 1996; Goupil, 1996; Lewis and Fabisial, 1997), and ε-caprolactone with glycolide 
(Schindler et al., 1977), yielding materials with more rapid degradation rates, and lower 
stiffness compared to pure polyglycolic acid (PGA), respectively. 
 
Since PCL is an aliphatic polyester which is composed of hexanoate repeats, it’s physical, 
thermal and mechanical properties depend on two key factors, which are firstly, its 
molecular weight and secondly, it’s degree of crystallinity (Labet and Thielemans, 2009). At 
ambient temperature, it is also known to be soluble in a variety of solvents, which include 
but are not limited to, chloroform, dichloromethane, carbon tetrachloride and benzene. It is 
also insoluble in alcohols, petroleum ether, diethyl ether and water (Sinha et al., 2004).  
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PCL has many properties and characteristics that make using it as an additive in compounds 
very attractive. These include biodegradability, which is conditional on the molecular 
weight, crystallinity and the environment which the PCL is in (Chen et al., 2000; Pen ̃ a et 
al., 2006; Lam et al., 2000). The dependence of molecular weight and the PCL properties 
are displayed in Table 2.1 below. It is miscible with many other polymers like poly(vinyl 
chloride), poly(styrene–acrylonitrile) and other polycarbonates. It has also been proven to be 
mechanically compatible with other polymers and naturally occurring compounds such as 
polyethylene, poly vinyl acetate and rubber.  
Table 2.1: Properties of PCL (Labet and Thielemans, 2009) 
 
 
 2.3.2   Polycaprolactone in Tissue Engineering 
 
Polycaprolactone has been used extensively with many other compounds and materials to 
produce scaffolds for tissue engineering (Agrawal and Ray, 2001). There has been extensive 
work done using PCL for bone tissue engineering. This is due to its physical and chemical 
properties, which make it ideal for use as a scaffold. 
 
 Williams et al. (2004), did a study using PCL scaffolds made using SLS (Selective laser 
sintering), seeded with bone morphogenetic protein-7 transduced fibroblasts in order to test 
with others (polyethylene, polypropylene, natural rubber, poly-
(vinyl acetate), and poly(ethylene–propylene) rubber).
PCL biodegrades within several months to several years
depending on the molecular weight, the degree of crystallinity
of the polymer, and the conditions of degradation.6–14 Many
microbes in nature are able to completely biodegrade PCL.6
The amorphous phase is degraded first, resulting in an increase
in the degree of crystallinity while the molecular weight
remains constant.9 Then, cleavage of ester bonds results in
mass loss.7,14 The polymer degrades by end chain scission
at higher temperatures while it degrade by random chain
scission at lower temperatures (Fig. 1).13 PCL degradation
is autocatalysed by the carboxylic acids liberated during
hydrolysis7 but it can also be catalysed by enzymes,
resulting in faster decomposition.11 While PCL can be
enzymatically degraded in the environment, it cannot be
degraded enzymatically in the body.8
PCL has uses in diﬀerent fields such as scaﬀolds in tissue
engineering,9,14–16 in long-term drug delivery systems7,10,11 (in
particular contraceptives delivery8), in microelectronics,17 as
adhesives,13 and in packaging.8 Its wide applicability and
interesting properties (controlled degradability, miscibility
with other polymers, biocompatibility and potential to be
made from monomers derived from renewable sources) makes
PCL a very useful polymer if its properties can be controlled
and it can be made inexpensively. A large number of catalysts
and catalytic systems, spanning virtually the whole periodic
table have been investigated. It is therefore paramount to have
a good understanding and overview of the diﬀerent catalysts
and catalytic systems that have been studied to drive new
developments in catalysis (whether organic-, metal- or
enzyme-based) or chose the appropriate system to obtain the
polymer with the desired characteristics. The former would be
of interest to anyone working on catalysis, whereas the latter is
more directed towards polymer chemists. This review aims
to be a reference work that can be used for this purpose.
Knowledge of ineﬀective systems is of equal importance and
they are described in the ESI.w
Preparation of the monomers
A number of microorganisms oxidise cyclohexanol into adipic
acid (Scheme 1).18 In this process, both e-CL and 6-hydroxy-
hexanoic acid are intermediary products. Industrially, e-CL
is produced from the oxidation of cyclohexanone by peracetic
acid (Scheme 2).19
Table 1 Properties of PCL
Properties Range Ref.
Number average molecular weight
(Mn/g mol
!1)
530–630 000 —
Density (r/g cm!3) 1.071–1.200 1,3–6
Glass transition temperature (Tg/1C) (!65)–(!60) 3–5, 7 and 8
Melting temperature (Tm/1C) 56–65 3–8
Decomposition temperature (/1C) 350 9
Inherent viscosity (Zinh/cm3 g!1) 100–130 5
Intrinsic viscosity (Z/cm3 g!1) 0.9 1
Tensile strength (s/MPa) 4–785 3, 5, 6 and 8
Young modulus (E/GPa) 0.21–0.44 3 and 5
Elongation at break (e/%) 20–1000 1, 3, 5, 6 and 8
Fig. 1 Cleavage of the polymeric chains during the degradation of PCL.
Scheme 1 Oxidation of cyclohexanol to adipic acid in Acinetobacter sp. strain SE19, adapted from Thomas et al.18
This journal is "c The Royal Society of Chemistry 2009 Chem. Soc. Rev., 2009, 38, 3484–3504 | 3485
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the mechanical properties of PCL in relation to bone tissue engineering. They discovered 
that the PCL when synthesized using SLS, supported bone regeneration, in particular, aiding 
the cortex of the bone which surrounds the marrow space to form. Judging by the data 
obtained, they concluded that the scaffolds would be able to withstand early functional 
loading and using the SLS, it would be able to fit the desired anatomical position in the bone. 
However, the use of the SLS method had some limitations, which were also pointed out by 
Williams and her colleagues that included particle size. Basically, if the particles were very 
large, then they increased the granularity of the edges and layers of the SLS produced 
scaffold and if the PCL particle size was very small, then the spreading properties and flow 
of the produced scaffold was highly limited.  
 
Shin et al. (2004), seeded rat osteoblasts on an electrospun PCL scaffold and cultured them 
for 4 weeks and then subsequently transplanted those seeded scaffolds in-vivo into rats. 
They observed that cell and extracellular matrix production were present throughout the 
scaffolds, also detected was mineralization and collagen type I. It was interesting to note that 
Shin et al., considered the electrospun PCL scaffold as a 3-D structure because large, 
interconnected voids were present between the fibres. They mentioned that normal 
mesencymal stem cells (MSC) seeded on PCL can produce alkaline phosphatase (ALP). 
However, it is generally considered negligible when compared to the amount produced by 
osteoblasts.  
 
There has been some encouraging research in using PCL as a bone patch to repair holes in 
the skull (Tan, 2004). Basically, Tan and his team used fused deposition modelling (FDM) 
in creating the 3-D PCL scaffolds required for this clinical application. FDM works by 
creating objects by extruding the PCL using an extrusion head by working on all the three 
axis’ (x, y and z) of a 3-D object. 
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2.4 PCL and HA Blends Used in Bone Tissue Engineering. 
 
Bone tissue regeneration is taking on an important role, in order to restore skeletal function 
with focus on orthopaedics. In most clinical situations, where orthopaedic surgery is 
required, there are limitations with regards to sources of bone graft materials. Generally, 
graft materials include autologous bone (from the patient), allogeneic bone (from a donor), 
and demineralized bone matrices, as well as a wide range of synthetic biomaterials such as 
metals, ceramics, polymers, and composites (Meijer et al., 2007). These limitations create a 
demand for materials that can be used in bone tissue engineering and electrospinning 
appears to fill the void. 
 
PCL has been used commonly as a synthetic biodegradable polymer for tissue engineering, 
however its use in tissue engineering is limited because of its inadequate mechanical 
strength and low bioactivity. A study was done using halloysite nanoclay (NC) as an 
inorganic filler material with PCL to prepare PCL/NC fibrous scaffolds via electrospinning 
(Nitya et al., 2012). The PCL/NC electrospun scaffold was found to be mechanically 
superior to the pure PCL electrospun scaffolds. It was also noted that the PCL/NC scaffolds 
has more protein adsorption and increased mineralization when incubated in simulated body 
fluid. The in-vitro results showed that the human mesenchymal stem cells (hMSCs) seeded 
on the PCL/NC scaffolds were viable and could proliferate faster than in PCL scaffolds as 
confirmed by fluorescence and scanning electron microscopic observations. An increase in 
ALP activity displayed osteogenic differentiation of hMSCs on the nanoclay embedded 
scaffolds. 
 
Professor Ramakrishna’s research team (Venugopal et al., 2007) in the National University 
of Singapore, did a study of PCL and HA using a 2% to 2% ratio of PCL and HA by 
	   	  21 
electrospinning the two. The only concentration used for HA was the 1:1 ratio with PCL. 
They discovered that after seeding osteoblasts for 6 days, there was some migration of the 
osteoblasts inside the nanofibrous scaffold and this was then translated into an increase in 
cell proliferation (measured by the MTT assay) over a 6 day period. ALP activity increased 
as well and was measured over time periods of 5 and 10 days. Their limitation in the 
experiment was however that only 1 concentration of HA was blended with the PCL and 
that besides FTIR, there was no further characterisation of the scaffold. Additionally, the 
HA used was obtained using synthetic techniques.  
 
Deepika et al. (2009) also used a co-polymer containing polycaprolactone and poly-lactic 
acid, mixed with hydroxyapatite. The purpose of creating this blend was to investigate 
whether the spraying of HA particles onto nanofibres was better than blending the HA 
particles with nanofibres. Their investigations showed that the electrospraying of HA 
particles helped to attain a rough surface, which aided in increased cell proliferation and 
attachment. It also aided in improved mechanical properties. Once again, osteoblasts were 
used in this study to observe the attachment of cells to the scaffold.  
 
Wei and Ma (2004) used another method that was used to create scaffolds. They employed 
thermally induced phase separation technique to create a nano-hydroxyapatite/polymer 
composite scaffold. The addition of HA increased the protein adsorption capacity of the 
scaffold and increased the mechanical properties. 
 
2.5 Electrospinning and its Applications in Tissue Engineering 
 
There has been recent interest in the use of electrospinning as a technology to fabricate 
scaffolds in tissue engineering due to a realization that electrospun scaffolds are highly 
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adaptable to different tissues, adding different additives and amounts can control the texture 
and thickness of the scaffold. The biodegradability of electrospun scaffolds is also 
controllable by blending different materials together, both natural and synthetic. Due to the 
nature of the fibre arrangement, one can even control the biological response of the scaffold. 
This added with the possibility of adding protein, DNA and RNA to the mix makes for a 
very exciting technology to be used in the fabrication of scaffolds (Sill and Recum, 2008).  
 
Electrospinning in tissue engineering takes into consideration various factors that need to be 
considered which include, but are not limited to the type of material being spun, the 
orientation of the fibre and the porosity of the scaffold that will be determined. The material 
of choice for electrospinning must be biocompatible and must take into consideration the 
final application for which the electrospun scaffold will be used for. For example, scaffolds 
required for bone tissue engineering need to be rougher in texture than those required for 
skin applications.  
 
Fibre orientation plays a big role in the type of tissue the electrospun scaffold needs to be 
utilized for. There is either aligned or random fibre orientation. Schnell et al. (2007), studied 
the effect of using aligned nanofibrous scaffolds, made from PCL and collagen/PCL, to 
control axonal outgrowth and glial cell migration in peripheral nerve regeneration. It was 
discovered that while both scaffolds facilitated oriented outgrowth of axons and glial cell 
migration, the collagen/PCL blend has given superior guidance to axons. 
 
By incorporating chitosan in PCL nanofibres, and seeding them with osteoblasts derived 
from mice, a group of researchers (Yang et al., 2009), found that SEM imaging showed that 
the whole construct surface was covered by cells and newly covered Extracellular Matrix 
(ECM). Additionally, the formation of integral tissue in the constructs without the 
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PCL/Chitosan nanofibres meant that the use of electrospun scaffolds in tissue formation 
aided immensely in creating a structure that will degrade over time leaving a proper fully 
formed tissue in place. 
  
The use of electrospinning in tissue engineering has also been explored in the area of heart 
tissue engineering (Zong et al., 2005). Cardiomyocytes were seeded on electrospun 
scaffolds made from non-woven poly(lactide) and poly(glycolide)-based (PLGA) scaffolds. 
In this experiment, the in-vitro studies showed a dose response effect of the PLGA 
concentration in the degradation rate together with a change in the pH value. In the SEM 
evaluation, it was noted that the fine fibre network of the matrix made it possible for the 
cardiomyocytes to crawl underneath fibre and thus, creating possible layers of tissue. By the 
use of confocal microscopy on the scaffolds, they deduced that the cardiomyocytes had a 
preference for hydrophobic surfaces.  
 
Ekaputra et al. (2009), fabricated electrospun PCL/Collagen fibre and seeded pig Bone 
Marrow Mesenchymal cells (pBMMCs) on these fibre. Their immunohistochemistry 
showed that the osteogenic differentiation markers were stronger when cultured with the 
collagen co-polymer as opposed to the pure PCL alone. However, the scaffolds had to be 
osteogenically induced by adding osteogenic cell sheets around the PCL/Collagen scaffolds 
and this in turn, aided the osteogenic differentiation as well. 
 
2.6 Stem Cells 
 2.6.1   Isolation and applications of stem cells 	  
Mature MSC possess differentiation potential into cells of bone, cartilage, adipose, muscle, 
tendon, ligament and marrow. These cells have been found in a variety of tissues which 
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include, but are not limited to, bone marrow, adipose tissue, synovium, dental pulp, cord 
blood and umbilical cord (Pittenger et al., 1999; Zuk et al., 2001; Sudo et al., 2007, Caplan 
et al., 2007). With specific regard to bone tissue engineering, the primary source of cells has 
been the bone marrow mesenchymal stem cells. The main reason is because these cells have 
proven over time that they are capable of bone and cartilage formation (Friedenstein et al., 
1987).  
 
Bone Marrow Stem cells are normally isolated based on their growth potential and their 
adherence to plastic. The aspirate can originate from rats, rabbits or humans. Irrespective of 
the source, generally all stem cells are seeded and passaged (also known as culture 
expanded) prior to testing. In passaging, the population doubles and can continue, as some 
research has shown up to 50 passages (Bianco et al., 2001). 
 
 2.6.2   Characterisation of stem cells 
 
In the characterisation of MSC, there are certain criteria that needs to be followed. These 
criteria have been set by the International Society for Cellular Therapy and these criteria 
include that MSCs must be adherent to plastic when maintained in culture (Dominici et al., 
2006). Secondly, the MSCs must be positive for the surface antigens CD105, CD73 and 
CD90. Additionally, the MSCs must be lacking in markers for monocytes, macrophages and 
B cells, as well as the expression of the haematopoietic antigens CD45(-) and CD34(-). For 
characterisation purposes, it is necessary to have a combination of some negative markers as 
well as at least one positive marker. Last but not least, the MSCs must have the potential to 
differentiate into osteoblasts, adipocytes and or chondrocytes under standard in vitro 
differentiating conditions (Rosenbaum et al., 2008).  
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2.7 The Effect of Scaffold Material on Stem Cell Differentiation 
 
The type of material that stem cells are seeded on can possibly impact the type of cell it 
forms. In light of bone tissue engineering, more and more researchers are moving towards 
materials that are osteoconductive, osteoinductive and are capable of osteointegration. This 
reasoning was brought about because it was established that cells are highly sensitive to 
their surroundings and environment (Stevens and Stevens, 2008). The reaction of the cells to 
the texture of the material, especially with regards to groves, ridges, wells and other features 
at both the micron and nanoscale level is now established (Stevens and George, 2005). 
 
Example, the use of hydroxyapatite to create a rougher surface which can induce cell 
differentiation was investigated by Deligianni and colleagues (2000). They used synthetic 
HA which was moulded into discs and these were then seeded with MSC and were observed 
for cell attachment, proliferation and differentiation. It was found that the addition of the HA 
increased the cell proliferation, adhesion and detachment strength. As far as the cellular 
differentiation was concerned, there has been  ALP activity recorded, however it was not 
statistically significant when it was compared with the positive control.  
 
2.8 Cellular Assay Measurements and Protocols 
 
Cellular measurements are important as they are used as a method of quantitative 
measurement. This adds a depth to the study that qualitative measurements are unable to 
provide. In addition they provide an overall picture to the experimental set up which allows 
for in-depth analysis of the different environments that the material and cells have been 
exposed to.  
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 2.8.1   Alamar Blue Assay 
 
The Resazurin dye or better known as the Alamar Blue assay, is a blue dye, which remains 
so until it is reduced to its pink form, as a result of metabolic activity. It can be measured by 
both absorbance and fluorescence.  
 
 2.8.2   Deoxyribonucleic Acid (DNA) Assay 
 
The DNA assay that was carried out was the Hoescht 33258 stain. It is part of the Hoescht 
family which is composed of 3 main stains. The Hoescht 33258 stain works off the basis of  
excitation spectra which is what is then used to pick up the DNA amount. It is a fluorescent 
dye which works by binding to the AT-rich part of the DNA which then allows it to quantify 
and detect DNA by graphing it logarithmically between the fluorescence reading and the AT 
base pairs.  
 
 2.8.3   Alkaline Phosphatase (ALP) Activity 
 
ALP is an enzyme that is released by osteoblasts and has thus been characterized as an 
osteoblast marker. An increase in the level of this enzyme is reflective of an increase in the 
activity of osteoblasts. 
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CHAPTER 3:   MATERIALS AND METHODS 	  
3.1 Introduction 
 
This chapter covers the various methodologies used for the extraction and cultivation of the 
stem cells used in the experiments to the production, and for the characterisation and 
isolation of the various materials used. The fabrication process of the materials and the 
various parameters used will also be discussed. The different biochemical assays utilized in 
measuring the performance of the cells with the various materials tested will also be 
discussed and elaborated upon. The overall methodology of the study is illustrated in Figure 
3.1.  
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Figure 3.1: Flow chart of methodology involved in the study 	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3.2 Preparation of Primary Culture Medium 	  
For the culture of bone marrow stromal cells, Dulbecco’s Modified Eagle Medium (DMEM) 
containing 10% foetal calf serum (FCS), 100 units/ml penicillin and 100 units/ml 
streptomycin was used. The flowchart below shows the preparation of the culture medium. 
 
 3.2.1   Isolation and culture of Rat Derived Bone Marrow Stem Cells (BMSC) 
 
In this study, BMSCs were obtained from young adult (5-6 weeks old, male, 150-170 
grams) Sprague Dawley rats supplied by the Animal house, Faculty of Medicine, University 
of Malaya. The BMSC isolation protocols were approved by the Animal Ethics Committee 
[Ethics number: BM/10/11/2008/KBM(R)], Faculty of Medicine, University of Malaya.  
 
BMSC isolation and culture protocols described by Maniatopoulos C. et al. (1988), were 
employed for this study with some minor modifications. All of the steps are illustrated in 
Figure 3.2. Basically, following spinal dislocation and immersion of whole animal in 70% 
alcohol solution for 5 minutes, femurs and tibias of Sprague Dawley rats were aseptically 
excised inside a laminar hood. Soft tissues attached to the excised bones was cleaned off and 
Add	  Penicillin	  and	  Streptomycin	  sulphate	  (GIBCO	  #	  15640)	  	  to	  1L	  Dulbecco’s	  Modi[ied	  Eagle	  Medium	  High	  glucose	  with	  Phenol	  Red	  
(Cellgro®	  #10-­‐013-­‐CM)	  	  	  
• Separately	  Aliquote	  1mg/ml	  solution	  of	  Penicillin	  and	  Streptomycin	  to	  make	  1%	  of	  the	  solution	  
Every	  100ml	  of	  DMEM	  solution	  add	  10ml	  Fetal	  Calf	  Serum	  and	  1ml	  Anitbiotic	  
• Mix	  solution	  well	  and	  store	  at	  4	  °C	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washed in culture medium (prepared previously Sec 3.2). The diagram below shows how the 
cells were isolated and cultured. Upon reaching confluence, the cells were then passaged, 
and all cells were cultured until passage 2-3, and seeded on the scaffolds when they were at 
those passages. 
 
Figure 3.2: Isolation and culture of Bone Marrow Derived Stem Cells. A: Sprague 
Dawley Rat is the source of the cells (5-6 weeks old); B: Cleansing of rat’s femur and 
tibia of any flesh; C: Cleaned bone is washed briefly in a solution containing a high 
concentration of antibiotics; D: The two metaphyseal ends of the bone are cut and the 
bone marrow is flushed out; E: Cell clumps are broken by repeated pipetting; F: Cell 
suspension is transferred to tube for centrifugation at 1500 RPM for 5 minutes; G: 
Cell pellet is re-suspended by repeated pipetting; H: Cells are seeded onto a T-75 flask; 
I: Cells are cultured in 5% CO2 incubator at 37 °C for 4 days. 
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 3.2.2   Cell seeding and incubation period 
 
The cells were then counted using a haemocytometer (described below) and were seeded on 
sterilized scaffolds at a density of 20,000 cells per cm2 inside 24 well plates and were 
labelled accordingly. 
 
The seeded scaffolds were then placed into the incubator for 2 hours. These scaffolds were 
then taken out and placed inside the sterile biosafety cabinet and the culture medium was 
added (this was done gently and from the sides so as to minimize the impact of adding 
culture medium to the cells which could result in cells being detached from the scaffold). 
Culture medium was changed regularly twice a week. The seeded scaffolds were cultured 
for time periods of 1, 7 and 14 days. At these time points, biochemical assays as well as 
SEM tests were carried out (described in Sections 3.6 and 3.7)  
 
A haemocytometer is a graduated counting chamber that can be observed under a 
microscope and is used to determine the concentration or number of cells in a suspension. In 
this experiment, a common Neubauer type chamber was used. The slide was divided into 4 
large squares in which the total number of cells were counted and processed according to the 
formula described below. 
 
A haemacytometer was used by first preparing a homogenous suspension of cells. It is an 
instrument used for counting the blood cells in a measured volume using a counting 
chamber of uniform depth that is covered by a ruled cover glass (Miller-Keane, 2003). This 
is normally done by pipetting cells post trypsinization. 20 µl was taken out of the cell 
suspension in the culture medium and then pipetted into a 1ml micro centrifuge tube. To this 
tube, 20 µl of Typan blue (caution: Trypan blue is a mutagen and must be handled with 
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care) was then added. The mixture was then pipetted thoroughly and 20 µl was then pipetted 
out under the glass cover slip and into the haemocytometer, where the number of live and 
dead cells were counted. The live cells shine brightly and the dead cells are stained with 
trypan blue. The total number of cells in the 4 squares (each square is 1 mm2) were counted 
and then processed according to the following formula to get the total number of cells per ml 
(Figure 3.3).  
 
  
 
Figure 3.3: Counting live and dead cells in a haemacytometer. (A) One chamber of a 
haemocytometer slide under 10x objective and 10x ocular. The chamber is divided into 
9 major squares. (B) Detailed view of one of the 9 major squares. Only cells that 
overlap the top and left borders of squares should be counted to avoid overestimating 
the cell concentration. O: cells that should be counted; Ø: cells that should be ignored 
(Image courtesy of qiagen.com) 
 
Formula for measuring the number of cells/ml:- 
 
 
 
  
           Dilution (ml of suspension)  
       
 
 
 
[(Total number of cells counted in 4mm2)÷ 4] x10000 
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3.3 Bovine Hydroxyapatite (BHA) Production 	  
Bovine bones (femur, tibia and metatarsus) were obtained from the local abattoir and then 
cleaned from macroscopic impurities and substances, including the ligaments and tissues. 
The bones were then defatted by boiling (1000 C) in distilled water for 3 hours, and dried in 
an oven at 70° C for 7 days in order to remove as much water content from the bones as 
possible. The purpose of defatting was to reduce soot formation during the heating process 
in the furnace. The dried bones were then ground into powder using a Schein Orthopaedic 
machine (T2002 ULTRA). The powdered bone was then sieved to between 25-40 µm. The 
sieved powder was then heated in a furnace to 1100° C at a heating rate of 10° C/min to 
obtain pure BHA (Herliansyah et al., 2006; 2009).  
 
Figure 3.4: Bovine Hydroxyapatite production. A: Raw bovine bones are defatted; B: 
Dried Defatted Bone; C: Dried bone is then ground into powder; D: Bone powder is 
obtained; E: Powder is then sieved between 25-40 µm; F: Sieved powder is then heated 
to 1100 °C in a furnace.  
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3.4 Polycaprolactone (PCL) and Bovine Hydroxyapatite (BHA) Scaffold Production 
 3.4.1   Solution preparation 	  
PCL (Mn = 80,000 g mol-1) was purchased from Sigma-Aldrich, USA. Chloroform and 
dimethylformamide (DMF), which were used as solvents for all the experiments, were 
purchased from Merck and Friendemann Schmidt, respectively.  
 
Solution blending of PCL and BHA was carried out in weight compositional ratios of 100:0, 
90:10, 80:20, 70:30, 60:40 and 50:50 respectively. PCL was first dissolved in a mixed 
solvent consisting of 9 parts chloroform and 1 part DMF using a magnetic stirrer at 50 °C for 
3 hours. After obtaining a homogenous solution, BHA was added and stirring continued for 
another 20 hours. In order to agitate and break possible random agglomerations of BHA, the 
solution was sonicated for 1hour.  
 
 3.4.2   Electrospinning 	  
The electrospinning set-up consisted of a syringe pump (Longer Pump, China), a 20 ml 
Terumo syringe, a needle (Terumo needle, 0.91×30 mm), a transformer (capable of 
generating voltage up to 24 kv) and a high voltage capacitor (Maxwell Laboratories Inc. 
USA, capacitance 0.22 µF, Voltage: 50 kV). The high voltage produced by the transformer 
was passed through a rectifier and a half-rectified DC current was obtained. The capacitor 
was used to decrease ripples and produce a more stable half-rectified DC wave. A piece of 
aluminium foil placed horizontally 18 cm from the needle tip was used as collector. The 
electrospinning was carried out while the syringe needle was positively charged at 12 kv and 
the syringe pump feeding rate was set at 3 ml/h.  The set-up was placed inside a tailor made 
transparent acrylic box. Some small holes were created in the walls of the box as outlets for 
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the evaporated solvent. A hygrometer (Hana Instruments, Romania) was used to monitor the 
humidity and temperature changes during the electrospinning process. The relative humidity 
varied from 60% to 75% during the spinning time and temperature changed in the range of 
28±2 °C. The resultant electrospun sheets were placed inside a vacuum oven at 40 °C for 24 
hours to remove any possible residual solvent. 
 
Figure 3.5: (i) Electrospinning machine setup which includes A: Box with minimal 
airflow for electrospun sheet; B: Syringe Pump; C: Aluminium sheet onto which 
electrospun scaffold was formed. 
 
 
Figure 3.5: (ii) Schematic diagram of electrospinning set-up (reproduced from Zhu 
and Chen, 2013) 
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For the electrospinning process, glass cover slips measuring 20 mm by 20 mm were stuck on 
the aluminium foil (Figure 3.6) (Venugopal et al., 2007). This was done mainly for two 
reasons, primarily to ease the peeling off of the scaffold sheet from the aluminium foil after 
it is electrospun as the sheet has a tendency to stick on the aluminium foil, which can cause 
a difference in the thickness of the sheet; secondarily, because having a rougher surface aids 
in the culture of cells. 
          (A)           (B) 
   
Figure 3.6: (A) Glass cover slips stuck on the aluminium sheet to prevent sticking of 
the electrospun sheet on the aluminium sheet. (B) Schematic representation of cover 
slips on aluminium sheet. 
 
The resultant scaffold sheet was cut into 1 cm by 1 cm squares (Figure 3.7) and sterilized by 
soaking the scaffolds in 70% ethanol at 4 °C overnight, then draining the alcohol and 
exposing the sample to Ultraviolet light for 3 hours (Tan et al., 2008). The reason they were 
soaked in alcohol was to disinfect the scaffold of any possible contamination. The scaffolds 
were then subjected to UV irradiation to remove any possible bacterial infection. 
 
Figure 3.7: Electrospun sheet is cut into 1cm by 1cm squares and placed in a 24 well 
plate for sterilization by alcohol and then UV radiation. 
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3.5 Bovine Powder Characterisation 
 
The Bovine Hydroxyapatite powder was characterized by using two main methods:- 
1) Fourier Transform Infrared Spectrometer (FTIR):  
Infrared (IR) spectrometer is used to see the vibrations of bonds (stretches and/or bends) 
of atoms present in a compound, thus providing evidence of the functional groups 
present in that particular compound. It measures the frequencies of IR light (wavelength: 
0.76 to 1000 µm) absorbed by a compound (Pavia et al., 2001). Fourier Transform 
Infrared spectrometer (FTIR) is the most modern infrared spectrometer (compared to 
conventional dispersive-type instrument) that uses an interferometer to measure a 
spectrum.  
 
The major advantages of using an FTIR spectrometer as opposed to using a dispersive 
instrument are (Wade, 2003): 
(a) It has the sensitivity required to measure all frequencies simultaneously, rather than 
scanning through the individual frequencies. 
(b) Less energy is needed from the source. 
(c) Less time is needed for a scan (typically 1 to 2 seconds). 
(d) Several scans can be completed in a few seconds and averaged to improve the signal. 
(e) Resolution and accuracy are improved as a laser beam is used alongside the IR beam to 
control the speed of the moving mirror and to time the collection of data points. 
 
A computer-interfaced FTIR spectrometer operates in a single-beam mode, but the spectrum 
obtained is identical to that from a traditional double-beam dispersive instrument. A 
“background” spectrum subtraction method is employed. First, an interferogram of the 
“background” (which consists of the infrared-active atmospheric gases, CO2 and water 
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vapour) is obtained and subjected to a Fourier transform which yields the spectrum of the 
background. Then, the spectra of both the compound and the background are obtained. The 
computer software automatically subtracts the spectrum of the background from the sample 
spectrum, yielding the spectrum of the compound being analysed. Commonly, a spectrum of 
a compound of interest is a plot of transmittance percentage (%) versus wave numbers (cm-
1).  
 
2) X-Ray Diffraction (XRD) 
XRD is a way to ascertain the arrangement of atoms inside a crystal which has been 
exposed to a beam of X-Rays. Once the beam strikes the crystal, the beam splits in 
various directions based on the constituents of the crystal. Based on the intensities and 
angles created by this splitting of the light beam, one can produce a 3-D picture of the 
density of electrons present in the crystal. This then aids in determining the position of 
the atoms in the crystals, the chemical bonds present in between them, the order in 
which they are arranged, and additional information regarding the interactions between 
the atoms in the crystal (Dutrow and Clark, 2013). 
 
In XRD, a crystal is mounted on a goniometer and turned whilst being exposed to X-Rays. 
This exposure produces a diffraction pattern of regularly spaced spots known as reflections. 
These reflections are in actuality 2D pictures, which are then converted into 3D pictures 
using the mathematical formula of Fourier Transform, which is then added to known 
chemical data of the sample. There is a possibility of error occurring if the crystals are not 
uniform enough in their internal structure.  
 
The main principles of XRD are based on some factors. The factors relevant to this thesis 
are: 
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(a) Atomic Form Factors: This works on the concept of Bohr’s atomic model. The electron 
density of the atoms will be associated with different distance vectors. These vectors are 
then in turn associated with variation in phase shifts. The smearing of the electron 
density exhibits a decrease of coherency and reduction in the scattered intensity. This 
then enables us to determine the phase shift of the crystal, hence reducing the number of 
possibilities.  
(b) Structure factor: Using the Bragg and Laue equations, it was found that there is only one 
atom per unit cell. The scattered intensity is then scaled with the square of the atom 
charge coupled with the interference function. The more complex a structure, the 
increase in the total charge distribution of the cell. 
(c) Multiplicity: this deals with the number of specific planes that may cause reflections at 
the same position. 
(d) Adsorption factor: This is where the X-Rays suffer from a reduction in their intensity, 
which is caused by their absorption. 
 
The results are then compared with the JCPDMS database. This is a database for inorganic 
compounds, which is then used to identify and match the peaks of the obtained graph with 
one that exists in the database. In this experiment, the obtained peak was matched to the 
peaks of hydroxyapatite available in the database. A Scan speed of 7° per minute and a step 
scan of 0.02° were used for this experiment. 
 
The non-sintered and sintered BHA powder was used, and a comparison was made and 
shown in the results. The HA powder was placed inside the Bruker AXS for XRD. Once the 
characterisation was done, the sintered BHA was sieved between 20-45 um. This was done 
so as to ensure that the particle size of the HA was optimum for cell culture (Quia et al., 
2006).  
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3.6 Composite Scaffold Characterisation 
 
The scaffolds were characterized in two ways. This was both physical and chemical. 
 
 3.6.1   Chemical characterisation 
 
Chemical characterisation was accomplished by using Fourier Transform Infra Red (FTIR) 
Spectroscopy in order to analyze the chemical bonds in between the polymers and 
hydroxyapatite scaffolds. All the produced scaffolds were analysed using a Fourier 
Transform Infrared Spectroscopy (FTIR-ATR) (Perkin Elmer Spectrum 400) powered by 
ATR technique. The spectra were collected at room temperature between 4000 and 400 cm-1 
at a resolution of ± 2 cm-1. 
 
 3.6.2   Physical characterisation  
 
Physical characterisation, was accomplished by using 3-D Confocal Laser Microscopy 
(OLYMPUS: LEXT OLS4000) which was carried out on the scaffolds in order to determine 
the thickness and roughness profiles of the scaffolds. This also included observing the 
surface hydrophilicity as well as fibre  diameter of the different scaffolds as explained below. 
 
  3.6.2.1   Scaffold roughness and thickness 
 
Scaffold roughness was observed by obtaining two different readings from the same 
machine i.e the 3-D Confocal Laser Microscopy (OLYMPUS: LEXT OLS4000). The 
machine allows us to determine the thickness and roughness profiles of the scaffolds. The 
procedure for obtaining this result was basically to use a standard cut piece of the polymer to 
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be tested and then place it under the microscope’s camera and set the software to scan the 
polymer’s layers after which it constructs an image based on the different planes of the 
polymer which are determined by the contours of the polymer. The image also enables it to 
determine the roughness by analyzing the planes and categorizing the polymer with less 
contours, as smoother and with more contours, as rougher by measuring the length and 
depth of the contours. 
 
  3.6.2.2   Surface hydrophilicity 
 
The scaffold surface hydrophilicity was assessed using the Contact Angle Analyser 
(DataPhysics OCA35 machine). This was done by placing the polymer under the camera 
lens of the DataPhysics OCA 35 machine (after making sure that the lens were set at a 
standard magnification for all the samples) and dropping water on the polymer. This is then 
subjected to a video recording by the system and analysed using the SCA20 software.  
 
  3.6.2.3   Fibre diameter 
 
The diameter of the fibres were measured using the FESEM (FEI Quanta FEG 250). 
Basically, once the image was taken, it was exported into Adobe Photoshop and using the 
measurement tool, 100 points of the fibre diameter were identified, measured and the length 
noted. These values were then analysed and plotted in Microsoft Excel to obtain standard 
deviation values and a graph depicting surface roughness (Figure 4.5) 
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3.7 Stem Cells Characterisation 
 3.7.1 Bone Marrow Stem Cell characterisation 
 
The isolated bone marrow stem cells were characterized in this experiment in four ways. 
The characterisation was carried out as previously described (Blanc and Rinde, 2007). The 
characteristics were identified as the ability to form fibroblastic colonies, adherence to 
plastic, tri-lineage differentiation capability (to Osteo, Adipo and Chondrogenic), expansion 
potential, MSCs stain negative by flow cytometry for haematopoietic markers; Cluster 
Differentiation marker 34, Cluster Differentiation marker 45 and Cluster Differentiation 
marker 14 and positive for Cluster Differentiation marker 73, Cluster Differentiation marker 
90 and Cluster Differentiation marker 105. In addition the regeneration and maintenance of 
a tissue compartment, multipotency and staining positively for mesenchymal markers are the 
characteristics of mesenchymal stem cells. The experiments that were carried out for 
characterisation of the isolated stem cells are listed as below: - 
 
  3.7.1.1 Adherence to plastic with fibroblastic features 
 
This was carried out by observing the attachment of the cells to the bottom of the T-75 
flasks via phase contrast microscope (Nikon Eclipse TS100) as shown in Section 4.6.1 This 
was also used to observe the expansion potential and the fibroblastic colonies that were 
formed.  
 
  3.7.1.2 Multi lineage differentiation potential 
 
BMSCs are able to differentiate into several specific mature cells under certain growth 
factors. Induction of BMSCs differentiation into osteoblast, adipocytes and chondrocytes 
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can prove the multipotent ability of BMSCs. At a minimum, it is advisable to differentiate 
the BMSCs into at least two lineages. StemPro® Chondrogenesis Kit (A1007101, Gibco) 
and StemPro® Osteogenesis Kit (A1007201, Gibco) were used to induce chondrogenesis 
and osteogenesis, respectively.  
 
  3.7.1.3 Chondrogenic differentiation:  
 
BMSCs were isolated and expanded with primary medium. The BMSCs were then passaged 
when cultures reach 60 – 80% confluency. BMSCs of passage between 2 to 6 were used in 
the chondrogenesis assay. BMSCs were harvested and seeded in 6-well plates at a cell 
density of 100 viable cells/5 µl medium droplet for 20 droplets per well. BMSCs were then 
left to attach to the culture surface in a CO2 incubator for 2 hours before adding with 
Chondrogenesis Differentiation Medium. To confirm chondrogenic differention, Safranin O 
staining was performed. In order to perform Safranin O staining, the medium was aspirated 
carefully from the well. The cells were then rinsed with distilled PBS. The cells were fixed 
by 10% Formalin for 5 – 10 minutes followed by rinsing with water. The fixed cells were 
put in 1.5% Safranin O for 40 minutes and followed by rinsing in distilled water for 3 times. 
The well was flooded with 0.02% alcoholic fast green for 30 seconds followed by 1% acetic 
acid 3 seconds. Then the well was rinsed quickly with distilled water. The well was then 
flooded with 95% ethanol for 1 minute. The cells were dehydrated in 2 changes of 100% 
ethanol with 1 minute each. The cells were then observed under an inverted microscope. 
 
  3.7.1.4 Osteogenic differentiation: 
 
BMSCs were isolated and expanded with primary medium. The BMSCs were then passaged 
when cultures reach 60 – 80% confluency. BMSCs of passage between 2 to 6 were used for 
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this osteogenesis assay. BMSCs were harvested and seeded in 6-well plates at a cell density 
of 3 x 103 to 5 x 105 viable cells/cm2. BMSCs were expanded in primary medium for 2 to 4 
days (to near or complete confluency) before being changed with Osteogenesis 
Differentiation Medium. 
 
Alizarin Red S staining was performed on BMSCs after the cells were incubated with 
Osteogenesis Differentiation Medium for 21 days. Alizarin Red S Solution was prepared by 
dissolving 2g Alizarin Red S powder in 100 ml distilled water. The medium was aspirated 
carefully from the well containing the cells exposed to the osteogenic differentiation 
medium. The cells were then fixed by incubating in ice cold 70% ethanol for 1 hour at room 
temperature. The alcohol was aspirated carefully and rinsed twice (5 – 10 minutes each) 
with water. The water was then aspirated and excess Alizarin Red Solution was added to 
cover the wells. The well plate was incubated at room temperature for 30 minutes. After 30 
minutes, Alizarin Red Solution was removed and the wells were washed for 4 times with 1 
ml water and aspirated after each wash. One to one and a half millilitre water was added to 
each well to prevent the cells from dying. The cells were then observed under an inverted 
microscope (NIKON TS 100) at non-fluorescent lighting conditions i.e normal white light.  
 
  3.7.1.5 Immunofluorescence staining for Mesenchymal markers 
 
Mesenchymal markers are used to identify various antibodies that indicate the presence of 
various cells, for eg. the mesenchymal markers vimentin, Twist, Snail, Slug and Sip1 are 
used to detect tumour cells in breast cancer patients (Kallergi et al., 2011). The markers 
CD44, CD105/endoglin, CD106/VCAM-1, collagen-IV, fibronectin, actin and DAPI nuclear 
staining can be detected by immunofluorescence staining and are used either collectively or 
individually to positively identify mesenchymal stem cells, the number used is dependent on 
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the additional tests (eg. Flow Cytometry marker identification) being carried out (Schieker 
et a., 2007). 
 
This was done following the procedure outlined in the lab manual prepared by Holmberg et 
al., from the Morimoto Laboratory, Northwestern University (Jolly C. et al., 1997 and Kim 
et al., 2002). The fixation solution (was made fresh in the hood). This was made by adding 
4.3 ml (4%) of 37% Formaldehyde (Acros Organics) to 35.7 ml of 1X PBS (Gibco). To this 
was then added 40 ml of 0.1 M Tris (Acros Organics). The detergent solution was made by 
adding 0.75 g (0.5%) of Saponin (Sigma) to 0.75 ml (0.5%) Triton X-100 (Fisher Scientific). 
Later, they were added to 150 ml of 1X PBS. The blocking solution was made by adding 1 
ml of FBS (Gibco) (10%), 0.03 ml of Triton X-100 (0.3%) and 8.97 ml of 1X PBS together. 
Washing solution was made by adding 6 ml of FBS (2%), 0.90 ml of Triton X-100 (0.3%) 
and 293 ml of 1X PBS together. A few drops of mounting (Antifade) Solution which is also 
known as D.P.X. Mountant (R&M Chemicals) was also used.  
 
After preparation of the solutions, 0.5 to 1.0 ml of cell suspension/well was added into the 4-
well chamber slides (Nunc) for 24 hours. The wells were then covered with a lid and 
incubated for 24 hours. The chamber slides were retrieved and the culture medium was then 
pipetted out. The plastic well and the rubber linings were removed, by using a given 
separator and forceps. The slides were then washed with 1X PBS in a coplin jar at room 
temperature for less than 3 minutes. The 1X PBS was removed and 40 ml of fixation 
solution was then added in the hood. They were then incubated at room temperature for 10 
minutes. A clean coplin jar was then added with 0.1 M Tris. The slides were then transferred 
to the 0.1 M Tris and incubate at room temperature for 5 minutes.1. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  Slides	  can	  be	  stored	  in	  1X	  PBS/0.01%	  NaN3	  after	  this	  step.	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The 0.1 M Tris was then removed and washed with 1X PBS for 3 minutes. The same goes to 
the 1X PBS and then the slides were washed 3 x 5 minutes in a detergent solution at room 
temperature. The samples were then placed in a clean coplin jar with 1X PBS. The slides 
were transferred to the 1X PBS and wash for 3 minutes. They were then removed from 1X 
PBS and 200 µl/slide of blocking solution was added. It was then covered with 22 x 60 mm 
cover glass, and incubated at 37 ºC for 45 minutes to 1 hour. The primary antibody was then 
diluted with the washing solution, and stored on ice or at 4 ºC. The cover glass was removed 
and 15 µl of the diluted primary antibody was added to each well. The slides had new cover 
glass placed over them, and were then incubated at 37 ºC for 1 to 1.5 hours. The washing 
solution was pre-warmed and placed inside a clean coplin jar in a 45 ºC water bath. The 
cover glass was removed and washed for 3 x 5 minutes in 45 ºC washing solution at room 
temperature. The secondary antibody was then diluted with the washing solution. 
 
Each well was then exposed to 15 µl of the diluted secondary antibody. The well was then 
covered with a new cover glass, and incubated at 37 ºC for 1 hour. The slides were then 
placed in a coplin jar with aluminium foil to protect them from light as the antibodies are 
light sensitive. The cover glass was then removed and washed three times for 5 minutes, 
each time, in 45 ºC washing solution at room temperature in the covered jar. Then DAPI 
staining is carried out by adding 15 µl of DAPI (1 µg/ml in 1X PBS), covered with a new 
cover glass and incubated at room temperature for 2 minutes. Then, the DAPI stained slides 
were washed twice for 3 minutes each with 1X PBS. Shake off the excess liquid from the 
slides. 5 µl of mounting solution is then added to each well, which is then covered with a 
cover glass and sealed with nail polish. The samples were then stored in a slide container at 
4 ºC prior to viewing under the Nikon TS 100 inverted microscope. The Nikon Eclipse 
TS100 is an inverted microscope with different filters used in the imaging process. The 
filters that were used were the NCB11, ND8 and GIF (green interference).  
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  3.7.1.6 Cluster Differentiation (CD) markers. 
 
Mouse anti rat antibodies with their fluorescent probes Cluster Differentiation 31-PE, 
Cluster differentiation 45-FITC, and Cluster differentiation 90-PerCP respectively were used. 
If these cells were BMSCs, they would yield negative for Cluster Differentiation 31 and 
Cluster Differentiation 45 and would be positive for the Cluster Differentiation 90 marker. 
 
The samples (newly isolated cells, P1) were incubated (5% CO2, 37 ºC). The cells were 
trypsinised at >80% confluence. They were then neutralized with 5 mL medium and the 
samples were filtered by using a cell strainer of mesh size 70 microns followed by 40 
microns. The filtered samples were then centrifuged for 5 minutes at 1000 RPM and the 
pellet was then resuspended with enough 1X PBS to adjust to the final concentration of 
approximately 10 million cells/mL, of which 4 ml was used in this experiment. One sample 
was prepared with all 3-colour combos and another three control samples that has a single 
colour each as described below. 
Staining (Direct2 and Live3 Method) 
 
 
 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 direct	  staining	  does	  not	  involve	  secondary	  antibodies.	  3	  live	  method	  is	  employed,	  therefore	  fixation	  and	  permeabilization	  steps	  are	  omitted	  as	  they	  are	  only	  for	  intracellular	  staining.	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Figure 3.8: Flowchart depicting a 3 colour combo sample preparation. 
  
Cell	  Suspension	  
• Cell	  suspension	  was	  incubated	  with	  all	  three	  κ-­‐isotype	  control	  IgGs	  (FITC,	  PE	  and	  PerCP)	  in	  a	  concentration	  of	  1	  µg	  per	  ml	  • This	  was	  done	  for	  10	  minutes	  
Antibody	  labelling	  
• The	  tubes	  were	  labelled	  of	  either	  FITC	  /	  PE	  /	  PerCP.	  	  • Another	  4	  tubes	  were	  prepared,	  and	  20	  µL	  of	  the	  [luorochrome-­‐conjugated	  antibodies	  was	  added	  to	  each	  of	  them,	  separately	  on	  each	  three	  tubes	  and	  all	  3	  antibodies	  on	  one	  tube.	  	  
Isotype	  Control	   • Add	  100	  µl	  of	  prepared	  cell	  suspension	  to	  each	  tube	  according	  to	  Isotype	  control	  	  • 4	  samples	  should	  be	  prepared	  as	  discussed	  in	  Table	  3.1	  	  
Vortex	  samples	   • Samples	  were	  then	  vortexed	  and	  incubated	  for	  15-­‐30	  minutes	  in	  a	  covered	  ice	  bucket	  • 1.5	  –	  2mL	  of	  1X	  PBS,	  was	  then	  added	  to	  each	  tube	  to	  wash	  off	  excess	  antibody	  
Obtaining	  pellet	   • Centrifuged	  in	  a	  tabletop	  microfuge	  for	  5	  minutes	  at	  2000RPM	  • Supernatant	  was	  then	  aspirated	  carefully	  	  so	  as	  not	  to	  disturb	  the	  pellet	  
Obtaining	  sample	  and	  running	  software	  
• Pellets	  were	  resuspended	  in	  500	  µL	  of	  1%	  paraformaldehyde	  and	  transferred	  into	  RBT	  polystyrene	  tubes.	  	  • Samples	  were	  then	  ready	  to	  be	  acquired	  within	  24	  hours	  exposure	  to	  light.	  	  • The	  test	  was	  then	  run	  using	  the	  BD	  FACSDiva	  software-­‐	  it	  is	  important	  to	  set	  the	  settings	  [lowrate	  in	  between	  10	  –	  120	  µL/min	  and	  run	  all	  4	  samples	  before	  moving	  on	  to	  the	  next	  step.	  	  
Data	  
• It	  was	  run	  at	  10,000	  to	  50,000	  events-­‐principle	  behind	  it	  explained	  in	  paragraph	  below.	  • The	  Data	  was	  then	  collected,obtained	  and	  anlyzed	  using	  the	  BD	  FACSDiva	  software	  as	  described	  above	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Table 3.1: Sample distribution for Flow Cytometry 
Sample Isotype Control 
Fluorochrome-Conjugated 
Antibodies 
 
Test Sample FITC + PE + PerCP FITC + PE + PerCP 
FITC Control FITC FITC 
PE Control PE PE 
PerCP Control PerCP PerCP 
 
The BD Facs Canto II works on the principle of a fluidic system. In the fluidics system, the 
sample travels up the sample injection tube, and hydrodynamic focusing within the flow cell 
forces particles into a single-file stream where laser light intercepts the stream at the sample 
interrogation point. This design permits particles to flow through the centre of the flow cell 
and by doing so, read the different events present and then characterise them based on the 
tandem dye conjugates. 
 
  3.7.1.7 Data analysis 	  
The BD FACS Diva software then collected the data related to voltage output. The voltage 
output was, in turn, translated in either its height or area to obtain the cell distribution, not 
width. This distribution can be viewed in all four samples or separately. The software can 
also isolate and observe dual population relationships, according to the need. The study 
acquired the dot plot data of side scatter vs. forward scatter for all four samples. This shows 
the distribution of cells according to the complexity vs. size (The steps are all in Uppercase, 
followed by the explanation of the steps). GATING: From the dot plot, the study drew a box 
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to gate the region of interest, excluding cell debris and any unwanted distribution. In case of 
BMSC, the cells may range from 10 to 40 microns. This was done for all 4 samples. 
SCALING: Next, at Cell count vs. Fluorescent histogram; the curve was fixed to log scale to 
get a proper fit of both the negative and positive population. COMPENSATION: Using the 
data from the single colour controls, two colour dot plots of each colour combination were 
drawn and the following pairs compensated: 
   i) FITC-%PE  ii) PE-%FITC  iii) PerCP-%FITC 
iv) FITC-%PerCP v) PE-%PerCP vi) PerCP-%PE 
The data plot was set on bioexponential scaling before compensating, in case of a value that 
may pile up on the axis and lead to error.  
 
After compensation, a Side scatter vs Forward scatter plot of CD90 was selected. Following 
this, the gate was set to the 10 to 40 micron region and a log scale histogram created from it. 
This reveals any positive and negative peaks of CD90 (Since it is hypothesized that CD90 is 
positive, there should not be any peak on the negative side). To look at CD45 and CD31 
antigens within CD90 positive, the CD90 positive peak was gated, and a dot plot of CD45 x 
CD 31 was created from it. The CD45 x CD31 dot plot was divided into 4 distinct quadrants 
such as in Figure 3.9. These quadrants translate as follows: 
 
 
Quadrant I:  CD45 (+); CD 31 (-) 
Quadrant II:  CD45 (+); CD31 (+) 
Quadrant III: CD45 (-); CD31 (-)  
Quadrant IV: CD45 (-); CD31 (+)   
 
Figure 3.9: Expected result of the 3-colour based experiment of BMSC 
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3.8 Cell and Scaffold Interactions 
 
FESEM was carried out on the scaffolds pre and post seeding. Post seeding, the time points 
were Day 1, 7 and 14. Since the FESEM used was the FEI Quanta FEG 250, no sample 
preparation was required as the samples were observed in a low vacuum.  
The FESEM images were used to: 
1) Observe and measure Fibre diameter. This measurement was done at 100 points on the 
image and the measurements were then processed in MS Excel. 
2) Calculate the porosity using the Image J software 
3) Observe cell attachment and morphology to the scaffolds on various days. 
 
3.9 Biochemical Assays 	  
There were three main biochemical assays carried out on the scaffolds, they were all 
quantitative and were measurements of the proliferation of the cells as well as the type of 
cells that were proliferating. The three tests were: - 
1) Resazurin (also known as Alamar Blue) cell proliferation assay. Used to measure the 
metabolic activity of cells. 
2) Alkaline Phosphatase (ALP) Assay, this assay is a measurement of the amount of 
alkaline phosphatase enzyme produced, which is an indicator of the amount of 
osetoblastic activity present in the cells 
3) Deoxyribonucleic Acid (DNA) Assay, this assay measures the amount of DNA present 
in the cells, and aids in giving a general idea of the number of cells (both live and dead). 
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3.10 Cell Proliferation Assay 	  
The resazurin test was carried out by initially creating a resazurin solution. This was done by 
using resazurin powder obtained from Sigma Aldrich, which was reconstituted by adding 14 
mg of Resazurin into 100 ml of culture medium DMEM-LG without Phenol Red: SIGMA- 
D9521. This was done following the manufacturer's instructions. All the samples and 
controls (24-well plate) were then washed gently three times with pre-warmed PBS prior to 
the Resazurin test. After the washing, 500 µl of medium (without Phenol Red) was added to 
each well. 50 µL of Resazurin solution (14 mg/100 ml phenol red-free medium) was added 
subsequently. The well plate was incubated for 4 hours. 10 minutes before the incubation 
time ended, the plates were covered with aluminium foil and placed onto the plate shaker 
and shook gently for 10 minutes. After shaking, the plate was transferred into the laminar 
flow hood. 100 µL from each well (24-well plate) was transferred to a 96-well plate in 
triplicates while still lights were off.  
1) The absorbance was measured at 690 nm and 600 nm using a FLUOstar OPTIMA BMG 
LABTECH micro-plate reader.  
2) The absorbance reading was then taken to be the metabolic activity of the cells (Fidalgo 
et al, 2010). 
 
3.11 Protein and DNA Extraction 	  
In order to obtain the protein and DNA from the cells to measure Alkaline Phosphatase 
Activity, the method previously described was followed (Zhao. et al., 2009). Briefly, the 
seeded scaffolds were washed twice in PBS after the Resazurin assay and placed inside 1.5 
ml micro-centrifuge tubes and frozen at -80 °C until the samples were processed further. 
The samples were then subjected to physical force and were frozen and thawed 3 times. The 
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thawed samples were then sonicated on ice and centrifuged at 12,000 RPM for 10 minutes. 
The supernatant obtained was then used to carry out protein and DNA testing.  
 
3.12 Alkaline Phosphatase (ALP) Assay Measurement 	  
Alkaline Phosphatase is determined by measuring the rate of hydrolysis of various 
phosphate esters under specific conditions. One of these esters is Nitrophenyl Phosphate 
(pNPP) and was introduced as a substrate by Fujita in 1939. Following that, Bowers and 
McComb reported an endpoint procedure in 1946. In 1974, the Committee on Enzymes of 
the Scandinavian Society of Clinical Chemistry and Clinical Physiology adopted a 
modification of the procedure as the recommended procedure. The method that has been 
followed in this thesis is based on the above mentioned methods with some addition by the 
methods followed by Wilkinson.et al., 1969. 
 
50 µl of the supernatant obtained was then added to 200 µl of pNPP solution (SIGMA 
ALDRICH: N1591) in a 96-well plate (TPP Corporation). This was then incubated at room 
temperature for 30 minutes. The reaction was then stopped by adding 50 µl of 3 M sodium 
hydroxide (NaOH) to the solution. The solution was then read at 405 nm absorbance. All 
absorbance readings were carried out using a BMG Labtech FluoStar Optima. The 
absorbance reading that were obtained were then processed using the following formula 
(this was done in order to change the absorbance to International Units) 
(IU/L)=Abs./Min x 1000 x 0.3= Abs./min x 2187 
                                                    18.75 x 1 x 0.050 
Where Abs./min = Average absorbance change per minute (in this experiment, the samples 
were incubated for 30 minutes)  
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1000 = Conversion of IU/ml to IU/L, 0.30 = Total reaction volume (ml), 18.75 = Millimolar 
absorbivity of Nitrophenol, 0.050 = Sample Volume (ml), 1 = Light Path in cm. 
   
 
3.13 DNA Assay Measurement 
 
In order to measure the DNA assay, first a DNA Standard solution has to be prepared. This 
is done by using calf thymus DNA (D1501) obtained from Sigma Aldrich. The DNA 
standard solution is then prepared by dissolving 50mg of calf thymus DNA overnight at 0-
4 ° C in 50 ml sterile PBS without sonication or stirring. In order to test for the purity of the 
DNA, the Optical Density was read in the ratio of OD260/OD280. This was done in order to 
make sure that the DNA is fully dissolved (the OD ratio should be above 1.8). OD260 is 
caused by constituents of DNA and OD280 is caused by contamination of DNA. The DNA 
strands were then pipetted around 40 times with a sterile glass Pasteur Pipette to shear the 
DNA, which was then filtered through a 0.45 um syringe filter. The precise DNA 
concentration by the OD260 reading was determined from a 1:20 dilution (a 50 ug/ml 
solution has an OD260 reading of 1.00). The aliquots were then stored at 4 °C. 
 
DNA measurement for samples was done by adding 2 mg Hoescht 33258, which was added 
into each ml of dH20 to make Hoescht stock solution, which was stored in 4 °C in a light 
tight bottle. Prior to use, the stock solution was diluted 10000x to 0.1 µg/ml in TEN buffer. 
Serial dilutions were made of the DNA standard at 25, 12.5, 6.25, 3.125, 1.5625 and 
0.78125 µg/ml. The original concentration was 50 µg/ml in 100 µl diluted in PBE. In a 96-
well plate, 10 µl PBE was added as a blank and a triplicate was made of this. The samples 
were added in the remaining wells. 200 µl of working solution was then added to each well 
prior to reading. The reading was done using fluorescence at 355 nm excitation, and 460 nm 
emission using a BMG Labtech FluoStar Optima, which automatically calibrates the 
readings to the prepared standard. 
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3.14 Statistical Analysis 
 
Using SPSS ver.18, a normal distribution of amount of Resazurin, ALP and DNA was 
verified by Skewness and Kurtosis methods (sample is normal if value of Skewness and 
Kurtosis is in the range of -1.96 to +1.96). When results from different runs for the static or 
a certain frequency of stimulation show normal distribution, the amount of Resazurin, ALP 
and DNA can be averaged to give a representative value for each of the frequencies tested, 
as for the static controls. 
 
A test of significance for the difference in the results between each group of samples can be 
done if each sample group is normally distributed. A one-way analysis of variance 
(ANOVA) was used to compare the groups. A value of p<0.05 was used to indicate 
statistical significance (Johnson, 2010). 
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CHAPTER 4:   RESULTS 	  
4.1 Introduction 
 
In this chapter, the results obtained are reviewed in a comprehensive manner. At certain 
points, the figures and tables will be elaborated together with the analysis below the figures 
and results. Briefly, the results of the characterisation will be seen, and these will form a 
prelude to the cellular assays and the biochemical tests, which should give us an idea of the 
relationship between the materials investigated and their effects on cellular growth. 
 
4.2 Bovine Hydroxyapatite (BHA) Characterisation 
 4.2.1   X-Ray diffraction of BHA 
 
	   	  
Figure 4.1: XRD profile of BHA (pre and post sintering) 
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The above figure shows the difference in the sintered and non-sintered XRD profiles from 
the three parts of the bones. As can be observed from the above figure, the XRD profile for 
sintered bone powder (i.e. Hydroxyapatite) is the same irrespective of the part of the bone 
from which it originates. Further, it was noted that in stark contrast to the unsintered bone 
powder, it shows the presence of many organic substances. In the sintered profile only the 
inorganic profile of Hydroxyapatite can be seen, hence showing that the sintering gets rid of 
any other possible compounds which may have affected the cellular assays. All the peaks for 
the sintered HA are consistent with those of 211, 300 and 202, hence showing the XRD 
result is consistent with the peaks required for HA. 
 
 4.2.2   Fourier-Transform Infra Red Spectroscopy of BHA 
	  
Figure 4.2: FTIR spectra for BHA. The figure shows the pre-sintered and post-sintered 
peaks of bone powder and BHA isolated from femur, tibia and metatarsus. a) Tibia 
pre-sintered, b) Metatarsus pre-sintered, c) Femur pre-sintered, d) Tibia post-sintered, 
e) Metatarsus post-sintered, f) Femur post-sintered 
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FTIR was carried out to enable us to compare the pre and post sintered BHA powder to 
observe the structural evolution of the BHA powder. It was also essential to couple it 
together with the XRD reading to ensure that the BHA produced has the same characteristic 
peaks of the standard HA. The FTIR was important in determining that all the BHA 
obtained was the same irrespective of which part of the bone it came from. 
 
4.3 Composite Scaffold Characterisation 
 4.3.1   Fourier-Transform Infra-Red (FTIR) spectroscopy of  composite scaffolds 
 
FTIR for the composite scaffolds was carried out to ensure that the amount of BHA added to 
the polymer was consistent with the solution blend, as the BHA had a tendency to settle to 
the bottom of the syringe while electrospinning. It was noted that the increase of HA 
percentage was in tandem with the increase of HA added. Figure 4.13 shows that the 
relationship between the increase of BHA powder and the increase in the phosphate group is 
directly proportional.  
	  
Figure 4.3: FTIR spectra of PCLHA composite scaffolds. A) PCLHA50%, B) 
PCLHA40%, C) PCLHA30%, D) PCLHA20%, E) PCLHA10% and F) PCL. 
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 4.3.2   Electrospun scaffold profile  
           4.3.2.1   3-D Confocal roughness profile of electrospun scaffolds 	  
	  
 
Figure 4.4: 3-D Confocal images of scaffolds. A) PCL, B) PCLHA10%, C) PCLHA20%, 
D) PCLHA30%, E) PCLHA40% and F) PCLHA50%. 
 
The above figure shows a distribution of the surface roughness of the various scaffolds, 
showing that the addition of HA in respect to the roughness ratio is highest in PCLHA30%. 
This result was slightly unexpected, as logically it was expected that PCLHA50% would 
possess the highest roughness value.  
 
There are a few reasons why this may have occurred; the HA distribution in the scaffold was 
uneven, a problem faced due to the micron size of the HA, which was difficult to electrospin 
as the concentration of HA became higher; and, there were more HA particles, which made 
the electrospun fibres heavier and harder to have an even distribution of HA. This was 
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manifested by the consistent clogging up of the syringe used in the electrospinning set up 
and in the uneven texture that was noted in the electrospun scaffolds. 
 
The roughness profile was conducted on a section of the electrospun scaffold. This has been 
one of the limitations of using this machine as the roughness profile is calculated only on 
one section of the scaffold as opposed to the whole electrospun sheet. 
 
 4.3.2.2   Roughness profile of scaffolds 
 
	  
Figure 4.5: Roughness profile of scaffolds 
The above graph compliments Figure 4.4 and confirms that the scaffold with the most 
roughness is PCLHA30%, followed by PCL, then PCLHA40%, PCLHA50%, PCLHA20% 
and then PCLHA10%. 
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4.3.2.3 Surface hydrophilicity  
 
The graph below shows the contact angle measurements demonstrating a steady decline in 
the contact angle along with an increase in the BHA concentrations, exhibiting an inversely 
proportional relationship between BHA concentration and contact angle. The contact angle 
is important as it exhibits the extent of hydrophobicity or hydrophilicity of a material. As 
can be seen in the graph (Figure 4.6) plotted below, the contact angle is the lowest for 
PCLHA50% which means that it is the most hydrophilic and should be amongst the better 
scaffolds for cell proliferation. The most hydrophobic is the PCL scaffold, which according 
to these results should have the least cell growth. This information is additionally displayed 
in Table 4.1. 
 
 
Figure 4.6: Contact angle measurements of scaffolds with different BHA 
concentrations. 
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Table 4.1: Contact angle and surface roughness measurements of scaffolds. 
Sample Contact Angle Standard 
Deviation 
Surface Roughness 
(µm) 
PCL 130.40 ± 5.54 9.28 
PCL - HA 10% 136.66 ± 4.37 4.35 
PCL- HA 20% 133.85 ± 9.60 6.38 
PCL - HA 30% 129.18 ± 5.36 10.14 
PCL - HA 40% 127.66 ± 11.79 8.36 
PCL - HA 50% 126.87 ± 9.79 6.39 
 	  
  4.3.2.4   Fibre diameter 
 
The FESEM images were taken in order to study the morphology of the scaffold prior to 
seeding as well as to determine the diameter of the fibres both with and without HA, as well 
as with the different concentrations of HA. This was essential as whether the cells would be 
able to seed on the fibres needed to be ascertained or if they would “slip through” the fibres 
and not be seeded properly.  
 
As observed in Table 4.2 the fibres are distributed in an uneven fashion, however in the 
process, they created different layers, which act as a 3D layer of sorts. There is plenty of gap 
and support for the cells to attach themselves to and create layers. The fibre diameter is 
essential as it enables us to observe the difference in fibre thickness across the different HA 
percentages added. It is a mechanism to test the distribution of the HA, as can be observed, 
the distribution of HA and fibre diameter appears to be standard. 
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Table 4.2: Fibre thickness graph. All FESEM images were taken at 1000x 
magnification. The average diameter distribution is shown on the right of the 
individual image. 
 
Scaffold Fibre Thickness Graph 
 
PCL  
 
PCLHA10% 
 
 
PCLHA20%  
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PCLHA30% 
 
 
PCLHA40% 
 
 
PCLHA50% 
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4.4 Stem Cells Characterisation 
4.4.1   Adherence to plastic with fibroblastic features 
 
This was done to observe the fibroblastic colony formation during the attachment of the 
cells to plastic as well as expansion potential of the cells. The bone marrow cells are 
growing and forming wave like structures showing the fibroblastic nature of the cells as seen 
in Figure 4.7. MSCs are very similar to fibroblasts in their features, and so form similar 
colonies of cells, especially on a 2D plane. 
	  
Figure 4.7: Cells attached on plastic (T-75 flask) - scale bar 200 µm 
 
  4.4.2   Multilineage differentiation of potential 
             4.4.2.1   Chondrogenic differentiation 	  
The cells were induced to differentiate into chondrocytes as indicated in Figure 4.8, 
although the staining was not as clear as the Alizarin stain. The cartilage was stained by 
Safranin O, producing a yellow-orange colour which is considered stained very mildly as 
true cartilage would be stained in an orange-red colour. The cytoplasm was stained bluish 
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green by fast green dye. However, chondrogenesis was proven by production of cartilage, 
which can be observed in the image below. 
	  
Figure 4.8: Chondrogenic staining ̶  scale bar 1000 µm 
 
 4.4.2.2   Osteogenic differentiation 	   	  
Calcium deposits were stained red by Alizarin Red Solution. It is important to note that the 
reason calcium stains were used is that they are a precursor to osteoblasts and these stain 
bright red, making it easy to observe a calcium stain.  
	  
Figure 4.9: Alizarin staining. 1000x magnification. 
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  4.4.2.3   Immunofluorescence staining of Mesenchymal markers 	  
DAPI staining was performed to observe the nuclei as in Figure 4.10. It works by binding to 
the A-T regions of the DNA. The biggest benefit is that it can pass through an intact cell 
membrane and thus, is used to stain both live and fixed cells. α-SMA, also known as alpha 
smooth muscle actin, is generally used as a marker for myofibroblast formation.  
	  
Figure 4.10: Immunofluorescence staining for α-SMA and vimentin. Cultured MSCs 
express both α-SMA (A) and vimentin (B), and negative control (no cells) that were 
stained with both antibodies as shown in (C). Cultured MSCs stained with both 
antibodies express on (D). Nuclei were stained with DAPI. Scale bar 100 µm. 
 
 
 4.4.3   Cluster Differentiation (CD) markers 	  
Figures 4.11 – 4.13 show images of cells corresponding to the CD markers. 2 negative and 1 
positive set of CD markers were coupled with the previous test show that the cells used in 
this study were BMSCs. 
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Figure 4.11: This shows the total distribution of the cells. As can be seen, gates are 
formed in order to confine the marker testing to a certain area. 
 
 
	  
Figure 4.12: In the above image, two distinct populations can be observed. These 
populations exhibit CD90-, CD31- and CD45+ markers.  
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Figure 4.13: As shown above it can be observed that the BMSCs exhibit positivity and 
negativity for CD90+, CD31- and CD45- markers. 
 
Flow cytometry analysis has shown that the majority of the isolated cell populations are 
CD31-/CD45-/CD90.Thy1+ (41.1%) and CD31-/CD45+/ CD90.Thy1- (48.3%). A total of 
41.1% of the population were phenotypically characteristic of mesenchymal stem cells 
(MSC) and were negative for endothelial marker CD31 and hematopoietic marker CD45 but 
positive for CD90.Thy1, which is a general marker for three types of cells: endothelial cells, 
hematopoietic stem cells and MSCs (32). Because CD31 was negative, it is safe to conclude 
that the expression of CD90.Thy1 represented MSCs alone. A total of 48.3% of the 
population were fibrocytes (33,34), which are mesenchymal precursor cells that can 
differentiate into myofibroblasts and fibroblasts. The presence of fibrocytes agreed with the 
hypothesis that plated cells may differentiate into the fibroblastic lineage by default. 
Because the flow cytometry samples were tested after the first passage in T-75 culture flasks, 
it is possible that some of the MSCs had differentiated into fibrocytes.  
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Table 4.3: FESEM Images over days 1, 7 and 14. All FESEM images were taken at 
2000x magnification and scale bar 50 µm. 
Scaffold	   Day	  1	   Day	  7	   Day	  14	  
PCL	  
	   	   	  
PCLHA-­‐
10%	  
	   	   	  
PCLHA-­‐
20%	  
	   	   	  
PCLHA-­‐
30%	  
	   	   	  
PCLHA-­‐
40%	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4.5 Cell and Scaffold Interactions 
 
The FESEM images were taken on Days 1, 7, and 14 (Table 4.2) at a magnification of 
1000x for a qualitative analysis. This was done so as to observe the cell attachment on the 
different scaffolds. As can be observed from the table above, the cells were forming layers 
of hardened material by day 14. On day 7 it is possible to note the cells attaching themselves 
to the fibres and beginning to fill in the “pores” made in between the fibres. On Day 1, it can 
be observed that the cells have been seeded the day before just beginning to settle in the 
scaffold.  
 
4.6 Biochemical Assays 
 4.6.1   Cell proliferation  	  
As seen in Figure 4.14, the Resazurin reading on Day 1 is very similar, showing that the 
seeding density was similar on all the scaffolds. There are no significant differences between 
the different scaffolds on Day 1. Day 7 showed that PCLHA30% was significantly lower 
(p<0.05) than when compared to Thermanox on Day 7. Day 14 exhibited a sharp increase in 
PCLHA30%, which was outstripped by PCLHA40%, which exhibited the highest peak. In 
order of the highest to the lowest metabolic activity on Day 14, the groups are; PCLHA40%, 
Thermanox, PCLHA50%, PCLHA30%, PCL, PCLHA10% and lastly was PCLHA20%. 	  
PCLHA-­‐
50%	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Figure 4.14: Cell metabolic activity over 2 weeks of cells seeded on all scaffolds. 
 
Within the days it was found that on Day 1, all scaffolds except PCL and Thermanox, were 
significantly lower (p<0.05) when compared against PCLHA40% Day 14. When Day 7 
samples were compared to Day 14 samples, it was found that PCL Day 7 was significantly 
lower than PCLHA40% Day 14. PCLHA10% Day 7 was significantly lower than 
PCLHA40%, PCLHA50%, Thermanox samples on Day 14. PCLHA20% was significantly 
lower than PCLHA40% AND Thermanox day 14. PCLHA30% was significantly lower than 
PCLHA30%, PCLHA40%, PCLHA50% and Thermanox Day 14. PCLHA40% was 
significantly lower than PCLHA40% and Thermanox Day 14. PCLHA50% was 
significantly lower than PCLHA40%, PCLHA50% and Thermanox Day 14. On day 14, 
there was no significant difference between Day 14 samples of PCL, PCLHA10% and 
PCLHA20% when compared to the rest of the days. PCLHA30% was significantly higher 
than Thermanox Day 1 and PCLHA30% Day7. PCLHA40% was significantly higher than 
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all tested groups on Day 1 and 7. PCLHA50% was significantly higher than Thermanox Day 
1, PCLHA10% Day 7, PCLHA30% Day 7 and PCLHA50% Day 7. Thermanox Day 14 was 
significantly higher than when compared to Day 1, PCLHA 40% and Thermanox, and for all 
Day 7 scaffolds with the exception of PCL (n=16). 
 
 4.6.2   Alkaline Phosphatase (ALP) Assay 	  	  
	  
Figure 4.15: Alkaline Phosphatase measurement over 2 weeks. 
The figure shows the ALP readings that were recorded across all tested groups, however the 
reading peaked on Day 7 for PCL-HA(50%). This is probably due to the high HA 
concentration, which increases the osteoblastic differentiation potential of the material. 
Interestingly, on day 14 the highest peak recorded was from the PCL-HA (40%) group, 
which perhaps is an illustration of the cells beginning to adapt more to this concentration. 
There was no significant difference recorded between all the groups either between days, or 
within days (n=16).	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 4.6.3   Deoxyribonucleic Acid (DNA) Assay 	  
 
Figure 4.16: DNA Assay of seeded scaffolds over 2 weeks [n=16] (All error bars shown 
are Standard Error of Mean) 
 
As can be observed from the graph above, on Day 7, the highest DNA amount recorded was 
for PCL, this was in line with the Resazurin result for Day 7. On Day 7, the PCL scaffold 
was found to be significantly higher than PCL, PCLHA20% and Thermanox on Day 14. 
PCLHA10% on Day 7 was significantly higher than PCLHA20% and Thermanox samples 
on day 14. PCLHA20% Day 7 was significantly higher than Thermanox Day 14. 
PCLHA30% was not significantly different from any other scaffolds on both the days. 
PCLHA40% Day 7 was significantly higher than Thermanox Day 14, whereas Thermanox 
Day 7 found to be insignificant against any group on Day 7. However, Thermanox Day 14 
was significantly lower than all Day 7 scaffolds as well as PCLHA10% and PCLHA30% on 
Day 14. PCLHA20% on Day 14 was significantly lower than PCL, 
PCLHA10%,PCLHA30% and Thermanox on Day 7. PCLHA30% on Day 14 was 
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significantly higher than Thermanox Day 14. PCLHA50% on Day 14 was also found to be 
significantly higher than Thermanox Day 14. These results contrasted with the results of 
Resazurin for both Days 7 and 14. On day 14, the DNA assay showed that all the scaffolds 
yielded a lower DNA amount however, on Day 14 for Resazurin, all the scaffolds exhibited 
an increased metabolic activity rate.  
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CHAPTER 5:   DISCUSSION AND CONCLUSION 	  
5.1 Introduction 	  
This chapter focuses on the analysis of the results as well as presenting the conclusion 
derived from the analysis, with reference to the objectives highlighted in Section 1.6. 
Parallels will be drawn with existing research and future work potential will be highlighted. 
In the conclusion section there is discussion with an emphasis on objectives and how those 
objectives were achieved.  
 
5.2 Bovine Hydroxyapatite Characterisation  
 
Hydroxyapatite has been used extensively in and for cell culture. In contrast, combining 
biologically-produced micron-sized hydroxyapatite with a polymer has not been carried out 
previously. The XRD (Figure 4.1) confirmed the hypothesis that irrespective which part of 
the bovine bone was used, when it was prepared in the manner described previously 
(Herliansyah et al., 2006; Ooi et al., 2007; Herliansyah et al., 2009), pure hydroxyapatite is 
obtained from the bovine bone. The unsintered powder’s XRD profile exhibits the presence 
of many impurities which are non-existent in the sintered version, thus resulting in a purer 
HA product matching the JCPDS (Joint Committee on Powder Diffraction Standards) 
database for HA, which is discussed later. This result suggests that the bovine model is a 
stable system. The well-resolved XRD peaks of the sintered BHA powder (Figure 4.1) were 
within the 2θ range between 20º and 50º. When the XRD peaks of all the sintered BHA were 
indexed on the basis of hexagonal crystal system of space group P63/m with respect to the 
JCPDS database, the Bragg peaks of sintered BHA powder at ~ 22, 23, 26, 28, 29, 30-35, 39, 
40, 42, 46, 48 and 49˚ (2θ) were similar to the characteristic peaks of HA, which means 
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hydroxyapatite is obtainable from a bovine source which is both natural and easily 
replenishable. The FTIR (Figure 4.2) of the hydroxyapatite samples, both pre and post 
sintering, also showed loss of the organic bonds post sintering, thus confirming the XRD for 
the HA, which confirmed earlier work (Legeros, 2008). There, the band of OH- at 3290 cm-1 
was shown to disappear in sintered bovine bones, when compared to unsintered samples. 
This result suggests a dehydroxylation of sintered samples. Sintering has also caused 
decomposition of organic matter, with the FTIR spectra showing missing absorption peaks 
relating to carbonate at 870 to 880 cm-1 and 1300 to 1700 cm-1 in sintered BHA compared to 
unsintered samples. Overall, the FTIR spectra of BHA is reproducible regardless of which 
part of the bovine bone is used. 
 
5.3 Scaffold Characterisation 
 
The FTIR (Figure 4.3) that was carried out for the materials post electro spinning showed a 
clear distinction between the additional bonds created by the addition of the HA. The 
analysis carried out of the materials post electrospinning showed that the intensities of PO4-3 
bands ν3 (1020 to 1040 cm-1) and ν4 (560 to 565 cm-1) and -OH (620 to 630 cm-1) peaks 
increased as the weight % of HA is increased. 
 
5.4 Effect of Increasing Hydroxyapatite Concentration on the Scaffold Material 
 5.4.1   3D Roughness profile of scaffold 
 
It has been previously reported that surface roughness benefits protein absorption in culture 
medium, especially with regards to biofilms (Bos et al., 1999). While observing the 
roughness profile (Fig. 4.4 and Fig 4.5), it was difficult to establish an actual trend in the 
addition of hydroxyapatite; this was probably due to the size of HA being used. The size of 
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the hydroxyapatite as compared to previous studies was larger by approximately one 
thousand times. This was because this study used micron sized HA (25-40 µm) as opposed 
to nano-sized HA (50~200 nm) (Venugopal et al., 2007). One of the possible limitations that 
was observed in using this particle size was that, possibly, the HA was not distributed 
completely homogenously during the electrospinning process. Hence, in the roughness 
profile, which focused on a small select area of the scaffold, it was observed that it was 
difficult to establish a relationship between the concentration of the HA and the roughness 
of the sample. To overcome this limitation, the sample size was increased for the cellular 
assays to 16 samples per group per test point.  
 
 5.4.2   Hydrophilicity properties 
 
The increase of the HA content in the scaffold, reduced the contact angle of the scaffold 
(Figure 4.6), which in turn was better for cell-material interaction, as it decreased the 
hydrophobicity of the scaffold. The hydrophobicity has been known to be instrumental in 
affecting the cell growth and attachment to materials (Webb et al., 1998) and hence a 
reduction in the contact angle caused by the increase in HA concentration increased the cell 
attachment potential of the scaffolds. 
 
Both of these results were used to meet the first objective discussed in Chapter 1, section 1.6. 
This was an observation of the effect of increasing hydroxyapatite concentration on the 
material morphology and characteristics. 
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5.5 Stem Cells Characterisation 
 
According to Dominici et al. 2006, the criteria for cells to be classified as stem cells include 
adherence to plastic (Figure 4.7). The adherence was noticed under the phase contrast 
microscope, additionally since the cells were adherent and growing and were not washed off 
with the changing of the medium, adherence to plastic was concluded. Secondly, another 
characteristic is that they must be able to differentiate into different lineages. This was also 
proven (Figure 4.8 and 4.9) to be possible for the cells that were isolated and cultured in this 
experiment. Essentially, the staining of cells post differentiation proved that they can 
differentiate into different lineages. Thirdly, they should test positive for the presence of 
mesenchymal markers, including αsma and vimentin. This was also shown to be positive by 
staining green (Figure 4.10). Lastly, they should test positive and negative for certain 
markers. The cells used were shown to be positive for CD 90 (a fibroblastic marker) and 
negative for CD 31 and 45, which are markers for endothelial and haematopoetic cells 
(Figure 4.11, 4.12 and 4.13). In conclusion, upon looking at all the obtained results and the 
procedures followed, it was confirmed that the cells used in this study were mesenchymal 
stem cells derived from the bone marrow of rats. 
 
5.6 FESEM Images 
 
The FESEM images for the non-seeded or empty scaffolds showed that the hydroxyapatite 
was embedded on and around the PCL fibres (Table 4.2). This then enhanced possible 
differentiation. As was noticed in the FESEM image obtained for PCLHA40%, there was 
some calcification that was present after 14 days (Table 4.3).  
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5.7 Biochemical Assays 
 5.7.1   Cell Proliferation Assay 
 
The Resazurin profile (Figure 4.15), measures the metabolism of cells by a measurement of 
the reduction in the resazurin dye (Fidalgo et al., 2010). It showed that the highest increase 
in cell metabolic activity was in the PCLHA40% group followed by the PCLHA50%, then 
PCLHA30%. Resazurin showed that over the 14 day period, from day 1 up to 14 days, the 
PCLHA40% group showed a twofold increase which was quite extraordinary and was 
possibly due to the lower contact angle of the scaffold. The PCL only scaffold which has 
been investigated and reported extensively showed a limited increase, which was 
statistically lower than the PCLHA40% group. This result tackled the second objective 
(Section 1.6), which was observation of the effect of an increase of HA concentration on cell 
growth and proliferation. 
 
 5.7.2   Alkaline Phosphatase (ALP) Assay 
 
Whilst the PCLHA40% is not the highest tested concentration of HA, it was the second 
highest one and showed no significant difference in the ALP reading (Figure 4.17). This was 
probably because the ALP reading was taken on Days 7 and 14, so as to maintain similar 
testing time to the Resazurin testing time, however, it is believed that if the ALP had been 
tested until day 28, a significant increase in the activity of the Alkaline phosphatase enzyme 
would have been expected, which would have been directly proportional to the amount of 
HA present in the scaffold. This hypothesis can be made based on previous literature which 
showed that overtime on hydroxyapatite scaffolds caused ALP levels to increase (Qi et al., 
2013). This result tackled the third objective (Section 1.6), observation of the effect of an 
increased HA concentration on cell differentiation. 
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 5.7.3   Deoxyribonucleic Acid (DNA) Assay 
 
The DNA results proved to be difficult to analyse, as they exhibited contrasting results to the 
Resazurin results measured over Days 7 and 14. They showed a decline in the amount of 
DNA produced, which contrasted an increase in metabolic activity displayed in the 
Resazurin results. After careful analysis of the FESEM results together with the remaining 
results, it was observed that the cells are growing and proliferating, hence the conclusion is 
that there are two possible reasons for a decrease in the amount of DNA: Firstly, it may be 
due to the extraction of the DNA which was a method prescribed by Zhou et al. (2009), 
resulted in a loss of DNA material in the last 2 weeks of their 6 week experiment. 
Essentially the DNA measurement was dropping 1 µg a week for the last 2 weeks, when 
compared to this experiment which had a loss of 3 µg a week. Although this losses were 
greater in proportion to Zhou et al. (2009) the trend was similar. Secondly, looking at 
literature it has been reported in a study (Karlsson et al., 2003) which observed the seeding 
of osteoblasts on non-porous alumina that the Alamar blue showed a decline in the amount 
of cells on Day 14, than when compared to Day 7, however in contrast the DNA content 
went up on Day 14. Hence, there is a precedence of contrasting results between DNA and 
Alamar blue assays which has also occurred in this experimental set-up. 
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5.8 Conclusion and Future Work 	  
An electrospinning device was used to produce fibres within a micro range. Using this 
system, composites of PCL-BHA scaffolds were produced. This was the first time a 
biomaterial was made from micron sized naturally derived bovine hydroxyapatite 
electrospun with Polycaprolactone. It was possible, in addition to producing the biomaterial, 
to also study the effect of increasing the bovine hydroxyapatite in relation to a reduction in 
the polycaprolactone concentration. From this, it was possible to conclude that not only does 
this scaffold support the growth, proliferation and attachment of BMSCs and is hence, 
biocompatible and noncytotoxic to cells; but also to determine the ideal concentration for 
further additional tests (discussed in the following paragraphs).  
 
Alkaline phosphate is one of the common bone cell-specific markers used to assess the 
presence of bone cells, and from our preliminary study, it was shown these scaffolds are 
osteoinductive based on the presence of alkaline phosphate activity and in a manner which is 
not yet shown to vary based on the relative proportions.  
 
These results exhibited enormous potential in the differentiation and proliferation potential 
of PCLHA40%. It is recommended that in the future experiments are repeated, involving 
cell differentiation analysis, gene expression studies, and investigation of factors like 
RUNX2, Osteocalcin and ATF-4. The biggest challenge facing any researcher who may 
wish to carry these in-vitro tests, is the correct and effective methodology for extracting 
these factors and other proteins for measurement from the scaffold.  
 
In addition to these in-vitro tests, a future researcher should also carry out in-vivo testing to 
observe the bone healing effect of this biomaterial and to see if it can be used as a possible 
wound dressing in the future.  
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